Inflammatory bowel disease, strict (require KELA)

K11_IBD_STRICT

inflammatory bowel disease: A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions K11_KELAIBD	11298
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints K11_CROHN K11_ULCER K11_KELAIBD	11298
6. Filter based on genotype QC (FinnGen only)	11298

Control definitions (FinnGen only)

Control exclude: K11_IBD_STRICT_PSC
Control conditions: not K11_KELAIBD

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF9

NAME	K11_IBD_STRICT
CONTROL_EXCLUDE	K11_IBD_STRICT_PSC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!K11_KELAIBD
SEX
INCLUDE	K11_CROHN\|K11_ULCER\|K11_KELAIBD
PRE_CONDITIONS
CONDITIONS	K11_KELAIBD
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Inflammatory bowel disease, strict (require KELA) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64105	29608	34206
Only index persons	60335	28315	32020
Unadjusted period prevalence (%)
Whole population	0.90	0.85	0.96
Only index persons	1.14	1.04	1.22
Median age at first event (years)
Whole population	36.15	35.44	36.65
Only index persons	35.35	34.89	35.77

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11298	5907	5391
Unadjusted period prevalence (%)	2.19	2.01	2.38
Median age at first event (years)	36.94	34.48	39.64

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10091: Matched controls
100909

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

61.5

323.0

613

106

L04AB04

ATC

adalimumab; parenteral

14.8

323.0

886

654

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

710.4

323.0

344

K50.9

ICD-10 Finland

Crohn disease, unspecified

252.5

323.0

2054

102

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

857.3

323.0

3026

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

53.7

323.0

597

118

UJF92

NOMESCO Finland

Capsular endoscopy

18.5

323.0

954

566

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

86.1

323.0

389

UJF30

NOMESCO Finland

Ileoscopy through colon

19.6

323.0

4229

3580

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

175.3

323.0

563

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

190.4

323.0

420

K50

ICD-10 Finland

Crohn disease [regional enteritis]

409.3

323.0

434

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.4

323.0

4302

14592

L01BB02

ATC

mercaptopurine; oral

180.0

323.0

1275

P01AB01

ATC

metronidazole; oral, rectal

2.9

323.0

5023

25734

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

323.0

10091

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

682.1

323.0

1465

A07EC02

ATC

mesalazine; oral, rectal

1095.3

323.0

8850

662

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

235.9

323.0

2006

106

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

6376.2

323.0

1155

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

12.1

323.0

1309

1225

D94

ICPC

Chronic enteritis/ulcerative colitis

200.9

323.0

762

A07EC01

ATC

sulfasalazine; oral, rectal

8.9

323.0

2409

3451

H02AB07

ATC

prednisone; oral

5.9

323.0

2906

6473

K50.0

ICD-10 Finland

Crohn disease of small intestine

175.0

323.0

2030

145

L04AX01

ATC

azathioprine; systemic

85.6

323.0

4491

936

J01MA02

ATC

ciprofloxacin; systemic

2.9

323.0

4713

23125

K50.1

ICD-10 Finland

Crohn disease of large intestine

559.6

323.0

1845

4AA12

NOMESCO Finland

133.7

323.0

361

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

508.8

323.0

1096

A07EA06

ATC

budesonide; oral, local oral

148.1

323.0

4063

457

ZX120

NOMESCO Finland

Intravenous

5.2

323.0

1756

3904

K51

ICD-10 Finland

Ulcerative colitis

446.9

323.0

1263

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

323.0

3783

15108

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

9.6

323.0

2266

2965

H02AB06

ATC

prednisolone; systemic

7.4

323.0

7628

29712

K51.5

ICD-10 Finland

Left sided colitis

765.2

323.0

4757

119

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

286.7

323.0

4718

308

K50.8

ICD-10 Finland

Other Crohn disease

422.4

323.0

2376

A07EA01

ATC

prednisolone; rectal

260.9

323.0

636

UJF32

NOMESCO Finland

Coloscopy

19.5

323.0

7274

11773

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

918.3

323.0

355

A07EA02

ATC

hydrocortisone; rectal

211.5

323.0

3088

210

K51.8

ICD-10 Finland

Other ulcerative colitis

435.3

323.0

2030

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

650.5

320.8

316

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

145.9

305.7

325

4AB02

NOMESCO Finland

67.6

304.2

353

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

10.8

303.5

610

600

WX002

NOMESCO Finland

Sedation and analgesia

2.7

283.1

2266

9631

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

247.8

282.1

289

A07EC03

ATC

olsalazine; oral

360.9

281.5

283

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

707.6

280.7

276

K83.0

ICD-10 Finland

Cholangitis

15.4

270.9

460

312

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

267.1

2425

11038

C10AC01

ATC

colestyramine; oral

8.8

266.8

601

723

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

255.9

4167

25100

A02BC02

ATC

pantoprazole; systemic

2.0

244.8

6300

45419

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

253.1

241.3

247

JF1BD

NOMESCO Finland

Very extensive small bowel CT

35.3

235.1

308

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

234.9

2460

11960

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

220.9

2153

10039

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

3.2

214.7

1267

4329

A05AA02

ATC

ursodeoxycholic acid; oral

9.3

209.9

455

510

L04AC05

ATC

ustekinumab; parenteral

41.7

209.1

264

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.0

208.8

1333

4810

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.9

198.8

691

1478

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

6.4

190.0

528

863

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

27.1

188.7

264

100

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

11.4

184.1

357

324

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.9

182.5

814

2215

A07DA03

ATC

loperamide; oral

5.5

175.4

554

1061

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.0

174.8

1123

4040

1370

FHL

Colonoscopy, whole colon

30.5

172.0

233

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

169.5

3699

23826

3042

Kela drug reimbursment

+∞

164.0

157

253

Kela drug reimbursment

+∞

161.9

155

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.9

158.9

705

1903

4AA33

NOMESCO Finland

498.5

148.9

148

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

147.2

141

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

1319.9

133.6

130

L04AD01

ATC

ciclosporin; systemic

6.0

132.6

386

667

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.9

132.5

581

1547

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

651.6

130.8

129

Z93.2

ICD-10 Finland

Ileostomy status

31.4

128.9

173

C05AA08

ATC

fluocortolone; rectal, topical

2.2

127.0

1437

7002

JFB20

NOMESCO Finland

Ileocaecal resection

19.6

125.8

194

101

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

81.8

121.5

137

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.7

121.0

321

490

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.5

121.0

243

236

JF1AD

NOMESCO Finland

Small bowel CT

17.1

120.6

195

116

JFH10

NOMESCO Finland

Total colectomy and ileostomy

40.6

120.1

152

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

16.9

119.4

194

117

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

155.6

116.5

123

JFB00

NOMESCO Finland

Partial resection of small intestine

7.8

112.9

270

354

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

111.9

1288

6295

JFH11

NOMESCO Finland

Laparoscopic colectomy

374.8

111.6

112

5550A

ICD-9 Finland

Regional enteritis, Small intestine

287.3

111.2

113

N02BE01

ATC

paracetamol; systemic, rectal

1.7

110.0

8082

70444

3AC01

NOMESCO Finland

8.9

109.8

242

278

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

109.7

1129

5235

K92.1

ICD-10 Finland

Melaena

3.5

108.7

542

1602

H02AB09

ATC

hydrocortisone; systemic

4.9

108.3

375

792

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

43.7

107.6

134

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

107.6

1338

6762

5551A

ICD-9 Finland

Regional enteritis, Large intestine

+∞

103.3

K60.3

ICD-10 Finland

Anal fistula

5.1

102.3

338

678

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

7.1

102.2

260

374

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

178.5

101.5

106

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

208.1

99.6

103

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

100.2

99.1

109

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.1

97.9

567

1874

A02BC03

ATC

lansoprazole; oral

1.7

97.2

2462

15982

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

9.3

96.8

208

229

N02AX02

ATC

tramadol; systemic, rectal

1.6

96.2

3651

26451

UJF02

NOMESCO Finland

Peroral enteroscopy

14.2

94.5

164

117

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.8

94.5

334

721

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

166.6

94.3

A02BC01

ATC

omeprazole; systemic

1.7

93.7

2340

15095

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

92.4

697

2726

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

91.2

341

779

JFF10

NOMESCO Finland

Loop enterostomy

13.1

91.2

164

127

B03BA03

ATC

hydroxocobalamin; parenteral

3.1

90.6

533

1779

L04AA33

ATC

vedolizumab; parenteral

+∞

88.7

JHA00

NOMESCO Finland

Anal or perianal incision

5.5

88.5

272

502

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.9

88.2

302

630

WVA20

NOMESCO Finland

Medicine administration

4.6

87.9

318

703

H02AB04

ATC

methylprednisolone; systemic

2.0

85.1

1308

7148

M45

ICD-10 Finland

Ankylosing spondylitis

4.2

84.2

341

842

K51.4

ICD-10 Finland

Inflammatory polyps

287.4

83.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

81.2

2416

16262

A07AA09

ATC

vancomycin; oral

7.3

80.7

201

281

K56.7

ICD-10 Finland

Ileus, unspecified

6.2

80.3

225

370

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

80.1

1246

6827

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.4

79.6

301

696

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

78.6

1934

12326

J01MA12

ATC

levofloxacin; systemic

1.8

77.3

1515

8993

3005

Kela drug reimbursment

Tofacitinib

18.0

76.6

121

K61.0

ICD-10 Finland

Anal abscess

4.4

74.4

284

663

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

74.1

716

3193

L04AB06

ATC

golimumab; parenteral

7.1

73.9

187

268

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.9

73.2

251

525

R50.9

ICD-10 Finland

Fever, unspecified

1.8

72.8

1308

7528

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.2

72.4

202

331

6419

FHL

Other measure in this category

51.6

72.3

A02BC05

ATC

esomeprazole; systemic

1.5

70.7

3415

25661

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

29.6

69.4

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.0

69.4

420

1427

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

120.8

66.9

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

66.7

1490

FHL

Sigmoideoscopy (fiberscope)

21.3

66.5

UJK12

NOMESCO Finland

Peroral cholangioscopy

23.9

66.2

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.5

64.4

157

213

UJG02

NOMESCO Finland

Proctoscopy

4.2

63.9

252

607

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

100.7

63.9

JFF13

NOMESCO Finland

Terminal enterostomy

28.0

62.7

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

62.6

3376

25777

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

13.5

62.4

110

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.8

61.9

183

323

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

60.3

526

2222

J01DB01

ATC

cefalexin; oral

1.5

59.7

7759

69825

B01AB05

ATC

enoxaparin; parenteral

1.5

59.4

2256

15927

UJK02

NOMESCO Finland

ERCP

4.0

59.2

245

618

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

57.7

471

1916

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

57.5

853

4563

WW200

NOMESCO Finland

Immunization

3.0

56.8

338

1134

L04AA29

ATC

tofacitinib; oral

13.1

56.5

101

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

31.5

56.4

WX402

NOMESCO Finland

General anaesthesia

1.6

55.6

1488

9603

JAH00

NOMESCO Finland

Laparotomy

3.4

55.3

281

841

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

191.0

55.0

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.6

54.4

411

1604

UJD02

NOMESCO Finland

Gastroscopy

2.6

54.3

421

1667

UJF34

NOMESCO Finland

Left colonoscopy

7.8

53.5

126

163

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

68.1

53.1

D11

ICPC

Diarrhoea

1.8

52.6

1082

6462

B81

ICPC

Anaemia vit B12/folate deficiency

3.0

52.5

322

1104

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

10.7

52.5

103

TJF80

NOMESCO Finland

Ostomy education

6.3

52.3

143

229

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

51.7

565

2660

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

51.4

3992

32292

A06AC51

ATC

ispaghula, combinations; systemic

2.4

50.5

439

1850

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

14.4

50.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

50.0

1474

9733

L04AA01

ATC

[U] ciclosporin; systemic

4.3

50.0

193

457

107

Kela drug reimbursment

Pernicious anaemia

4.3

49.3

190

449

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

170.8

48.9

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.7

48.8

224

619

D16

ICPC

Rectal bleeding

3.5

48.8

238

691

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

47.7

1718

11897

M05BA04

ATC

alendronic acid; oral

2.3

47.3

466

2090

E0000UV

ATC

1.4

47.2

3402

27042

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

47.1

278

928

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

22.1

46.5

6403

FHL

Ileocal resection

60.3

46.3

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

46.9

46.0

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

13.4

46.0

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

34.9

45.6

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

11.2

45.5

D06BX01

ATC

metronidazole; topical

1.8

45.3

861

5003

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

44.0

431

1927

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

4.4

43.8

164

378

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

43.7

777

4416

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

43.7

367

1518

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.7

43.6

153

330

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

429.5

43.2

Z93

ICD-10 Finland

Artificial opening status

11.2

42.8

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

42.2

590

3074

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.2

42.0

231

736

D07AC01

ATC

betamethasone; topical

1.4

41.9

2733

21239

UJF30

SPAT

7.2

40.5

100

140

D18

ICPC

Change in faeces/bowel movements

3.3

40.0

211

652

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

39.9

3297

26614

UJH02

NOMESCO Finland

Anoscopy

2.3

39.7

376

1651

1380

FHL

Colonoscopy, left side

32.7

39.7

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

+∞

39.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

39.5

712

4062

4AC05

NOMESCO Finland

389.0

39.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

38.2

688

3918

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

37.7

627

3479

6410

FHL

Panprococolectomy and ileostomy

+∞

37.5

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

55.2

37.3

K56.0

ICD-10 Finland

Paralytic ileus

5.5

37.3

113

208

A02BA02

ATC

ranitidine; systemic

1.5

37.2

1352

9331

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

36.6

831

5086

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

9.4

36.0

JHD20

NOMESCO Finland

Incision of fistula-in-ano

4.1

35.7

142

348

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

35.6

235

847

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.1

35.1

114

227

JF2AB

NOMESCO Finland

Colongraphy with X-ray

9.9

34.6

J01FA10

ATC

azithromycin; systemic

1.3

34.4

5367

47142

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.3

34.3

343

1551

C05AA01

ATC

hydrocortisone; rectal, topical

2.1

34.3

387

1846

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.5

34.1

103

189

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

9.2

34.1

Z94.4

ICD-10 Finland

Liver transplant status

8.4

33.2

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

8.0

32.3

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

32.3

475

2523

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

32.0

3535

29525

K76.9

ICD-10 Finland

Liver disease, unspecified

3.6

31.9

148

415

SPAT1263

SPAT

Sampling

1.3

31.9

3518

29366

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.4

31.9

117

266

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

12.5

31.6

L88

ICD-10 Finland

Pyoderma gangrenosum

13.2

31.3

A07AA02

ATC

nystatin; oral

2.0

31.1

418

2145

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

30.9

301

1343

E86

ICD-10 Finland

Volume depletion

3.2

30.9

170

544

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

313.8

30.8

JH1CM

NOMESCO Finland

Perianal extensive MRI with 3 Tesla magnet

23.2

30.8

K61.1

ICD-10 Finland

Rectal abscess

8.6

30.7

6525

FHL

Enterostomy occlusion

29.4

30.6

J05AB11

ATC

valaciclovir; oral

1.5

30.1

999

6731

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

12.0

30.1

D01

ICPC

Abdominal pain/cramps general

1.6

29.6

882

5788

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

11.0

29.4

ZX112

NOMESCO Finland

Subcutaneous

2.8

29.2

190

678

J02AC01

ATC

fluconazole; systemic

1.3

29.1

3179

26411

JHD00

NOMESCO Finland

Anal dilatation

4.8

28.9

202

D99

ICPC

Disease digestive system other

4.0

28.8

116

289

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

6.1

28.5

131

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

28.2

7737

82082

JJC00

NOMESCO Finland

Allogenic transplantation of liver

10.4

28.1

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

282.3

27.7

JFA60

NOMESCO Finland

Stricturoplasty in small intestine

+∞

27.1

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

27.0

426

2319

D07AC13

ATC

mometasone; topical

1.3

26.8

2267

18125

E000001

ATC

1.4

26.7

1667

12702

6408

FHL

Colectomy and ileostomy

271.8

26.7

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

26.4

215

876

6402

FHL

Small bowel resection

14.7

26.4

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

7.5

26.2

D07AD01

ATC

clobetasol; topical

1.5

25.7

1123

8009

SPAT1255

SPAT

Intravenous administration of medicine

1.8

25.4

459

2617

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

25.2

224

959

J05AB01

ATC

aciclovir; systemic

1.4

25.2

1570

11952

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

25.0

459

2630

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.2

24.9

235

Z43.2

ICD-10 Finland

Attention to ileostomy

13.5

24.9

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

2.9

24.6

150

517

ZXC86

NOMESCO Finland

Use of endoscopic device

5.6

24.4

130

B02.9

ICD-10 Finland

Zoster without complication

1.9

24.3

358

1901

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

24.1

650

4158

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.1

24.0

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.7

23.8

164

610

J01AA02

ATC

doxycycline; systemic

1.2

23.8

6586

60616

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

23.7

146

507

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

23.7

2166

17462

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

23.4

2693

22379

5604

FHL

Vascular preparation or cannulation in the operating room

9.4

23.4

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.1

23.4

226

J01DA01

ATC

[U] cefalexin; systemic

1.2

23.3

5368

48335

SPAT1262

SPAT

Handing over of treatment supplies

1.4

23.3

1235

9134

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

23.2

983

6964

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

23.0

682

4463

WZC30

NOMESCO Finland

Teaching

1.5

23.0

934

6562

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

23.0

2649

22010

Y0599

ICD-8 Finland

Investigation of digestive system

3.0

22.8

134

452

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

22.6

494

2982

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

22.5

1202

8896

A01AB09

ATC

miconazole; local oral

1.6

22.5

569

3579

D07XC01

ATC

betamethasone, combinations; topical

1.5

22.3

850

5892

L52

ICD-10 Finland

Erythema nodosum

4.5

22.1

177

R01AD12

ATC

fluticasone furoate; nasal

1.3

21.9

2552

21204

R01AD08

ATC

fluticasone; nasal

1.3

21.7

2334

19192

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

21.6

646

4240

S18

ICPC

Laceration/cut

1.3

21.5

3019

25649

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.8

21.5

106

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

21.3

111

345

6455

FHL

Perianal fistula surgery

6.1

21.2

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.3

21.0

105

316

SPAT1131

SPAT

Colonoscopy

2.2

20.9

226

1063

K62.4

ICD-10 Finland

Stenosis of anus and rectum

8.0

20.9

4AA17

NOMESCO Finland

+∞

20.8

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

20.8

348

1933

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

20.8

2432

20193

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

21.5

20.8

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

20.7

277

1419

J01FA06

ATC

roxithromycin; oral

1.2

20.6

3123

26732

RD210

NOMESCO Finland

2.4

20.6

170

703

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

12.9

20.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

20.6

550

3509

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

20.5

519

3268

K60.4

ICD-10 Finland

Rectal fistula

7.7

20.4

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

20.4

512

3214

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

8.0

20.4

L01BB01

ATC

9.6

20.2

JFB30

NOMESCO Finland

Right hemicolectomy

3.2

20.1

105

327

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

20.1

483

2997

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

10.3

20.0

J01CA04

ATC

amoxicillin; systemic

1.2

20.0

7529

70847

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

19.8

1725

13763

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

12.5

19.8

B01AB10

ATC

tinzaparin; parenteral

1.7

19.7

429

2590

JF1CD

NOMESCO Finland

Extensive small bowel CT

73.6

19.7

D29

ICPC

Digestive symptom/complaint other

2.5

19.6

152

605

B80

ICPC

Iron deficiency anaemia

2.4

19.6

162

668

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.2

19.6

102

317

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.0

19.4

249

1257

K63.2

ICD-10 Finland

Fistula of intestine

12.6

19.3

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

5.2

19.2

113

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

19.2

910

6580

K65.0

ICD-10 Finland

Acute peritonitis

3.4

19.1

275

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.0

19.1

238

1187

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

19.1

318

1768

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

7.4

19.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.8

19.1

B04AD01

ATC

10.3

19.1

JFB96

NOMESCO Finland

Other partial excision of intestine

22.6

19.0

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.5

18.8

154

634

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

7.5

18.8

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.0

18.8

253

1302

6404

FHL

Hemicolectomy on the right

15.8

18.7

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

18.7

1658

13252

JFA76

NOMESCO Finland

Closure of fistula of small intestine

70.0

18.7

H20.1

ICD-10 Finland

Chronic iridocyclitis

3.1

18.5

104

342

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

6.3

18.3

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.5

18.3

150

617

R11

ICD-10 Finland

Nausea and vomiting

1.5

18.1

554

3653

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

18.0

230

1163

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

17.9

4006

35577

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

8.3

17.9

ICD-10 Finland

2.2

17.8

174

783

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

10.0

17.8

K85

ICD-10 Finland

Acute pancreatitis

2.6

17.7

131

512

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

17.7

UJF32

SPAT

2.6

17.7

130

505

SPAT1153

SPAT

Removal of sutures

1.3

17.7

2167

18040

WX110

NOMESCO Finland

Local anesthesy

1.2

17.6

6218

57630

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

17.6

211

1037

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

17.6

616

4191

WW500

NOMESCO Finland

Blood transfusion

1.9

17.5

258

1376

WX004

NOMESCO Finland

Patient-controlled sedation

4.4

17.5

144

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

17.4

469

3000

Z93.3

ICD-10 Finland

Colostomy status

4.2

17.3

159

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

17.3

1251

9702

UKC02

NOMESCO Finland

Cystoscopy

1.4

17.3

909

6693

K29.8

ICD-10 Finland

Duodenitis

3.7

17.3

208

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.1

17.3

188

890

JFA70

NOMESCO Finland

Suture of small intestine

6.7

17.2

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

17.1

222

1129

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

17.0

181

847

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

17.0

348

2066

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

16.9

2181

18250

R01AD09

ATC

mometasone; nasal

1.2

16.8

3770

33420

M25.5

ICD-10 Finland

Pain in joint

1.2

16.8

2136

17843

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

2.4

16.7

146

622

6522

FHL

Ileostomy

170.2

16.5

L04AB02

ATC

infliximab; parenteral

170.2

16.5

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

5.1

16.4

100

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

16.4

713

5069

N03AX16

ATC

pregabalin; oral

1.3

16.4

1597

12909

N20.1

ICD-10 Finland

Calculus of ureter

1.9

16.3

256

1395

K83.1

ICD-10 Finland

Obstruction of bile duct

3.1

16.3

300

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

16.3

375

2305

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

16.1

1127

8698

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

6.3

16.0

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

6.3

16.0

1470

FHL

Rectoscopy

3.8

16.0

177

A07AA11

ATC

rifaximin; oral

8.2

15.9

J01MA01

ATC

ofloxacin; systemic

1.5

15.9

506

3371

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.4

15.8

137

582

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

15.8

280

1593

R4190

NOMESCO Finland

Nutritional therapy

1.8

15.7

262

1460

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.6

15.7

195

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

15.6

228

1210

5609X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction

8.7

15.6

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

6.5

15.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

15.5

1387

11075

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.6

15.3

108

413

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

15.2

2191

18536

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

15.1

948

7183

SPAT1325

SPAT

Vaccination

1.2

15.1

2283

19404

J01FA09

ATC

clarithromycin; systemic

1.2

15.0

2497

21435

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

15.0

344

2112

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

15.0

223

1197

6451

FHL

Dilatation

3.9

14.9

158

B03BA02

ATC

cyanocobalamin tannin complex; parenteral

5.5

14.9

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

12.4

14.8

M03BX02

ATC

tizanidine; oral

1.2

14.7

5308

48880

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.1

14.7

169

820

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

14.7

2072

17469

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

3.9

14.6

156

C10AC02

ATC

colestipol; oral

6.1

14.6

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

14.6

621

4398

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

14.6

456

3024

A98

ICPC

Health maint/preventive medicine

1.4

14.5

9456

92321

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.2

14.5

235

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.6

14.5

106

412

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

8.4

14.4

A02BA03

ATC

famotidine; systemic

1.9

14.4

218

1175

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

3.5

14.4

194

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

14.3

5873

54612

E000002

ATC

1.4

14.3

861

6481

JFA96

NOMESCO Finland

Other local operation on intestine

17.0

14.3

K30

ICD-10 Finland

Functional dyspepsia

1.4

14.2

697

5070

K90.0

ICD-10 Finland

Coeliac disease

1.9

14.2

208

1111

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.2

14.1

136

612

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

3.7

14.1

167

R03AC02

ATC

salbutamol; inhalant

1.2

14.0

4291

38902

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

2.7

14.0

345

JJ5AT

NOMESCO Finland

10.0

13.9

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

13.8

160

777

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.3

13.8

131

586

K85.8

ICD-10 Finland

Other acute pancreatitis

3.8

13.8

155

SPAT1125

SPAT

Stoma care and guidance

3.0

13.7

272

A03BA03

ATC

hyoscyamine; oral

3.4

13.7

197

JFH31

NOMESCO Finland

Laparoscopic total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

+∞

13.5

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.3

13.5

199

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

13.5

807

6069

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

4.0

13.4

134

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

8.1

13.2

5589X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis

8.5

13.2

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

13.2

294

1795

56398

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Alia definita

40.1

13.1

WX892

NOMESCO Finland

Monitored bed care

1.5

13.1

458

3113

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

13.1

528

3699

D07AB08

ATC

desonide; topical

1.4

13.1

736

5482

R10.0

ICD-10 Finland

Acute abdomen

1.8

13.0

218

1217

5781A

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[MELAENA]

5.7

12.9

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

12.9

283

4312

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

2672

12779

2.43

313.35

1.7

1.4

titre

553.2

541.2

0.12

726

2408

(40768804) Tissue Pathology biopsy report

5474

35089

2.09

308.39

2.4

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1602

5277

3.37

307.65

1.9

1.8

g/l

1.2

1.3

0.96

1509

4855

(3006315) Basophils [#/volume] in Blood

9086

44639

6.29

307.65

14.6

5.7

e9/l

0.0

3.31

8535

38890

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

796

1733

4.87

307.65

1.6

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10899

93044

5.85

307.65

26.0

11.9

mg/l

15.2

22.5

178.86

9788

72044

(3002030) Lymphocytes/100 leukocytes in Blood

8507

43575

4.85

307.65

14.6

5.8

28.5

28.9

2.89

8266

40899

(3005719) IgG [Mass/volume] in Serum or Plasma

1839

6895

2.99

307.65

2.6

g/l

11.5

10.5

23.42

1713

6326

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3465

4981

9.59

307.65

2.1

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6761

43343

2.39

307.65

7.6

6.0

umol/l

10.6

11.2

3.75

6509

41038

(3021440) Promyelocytes/100 leukocytes in Blood

2526

6513

4.71

307.65

6.4

4.2

0.1

0.2

2.92

664

1669

(3022096) Basophils/100 leukocytes in Blood

8326

40418

5.03

307.65

14.6

5.9

0.7

32.13

8084

37899

(3024561) Albumin [Mass/volume] in Serum or Plasma

8960

33905

8.94

307.65

9.8

4.7

g/l

37.0

36.2

39.95

8725

31612

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1132

1793

6.91

307.65

3.4

6.3

iu/ml

698.3

1619.5

0.51

119

251

(42870588) Differential panel, method unspecified - Blood

7115

29335

4.85

307.65

12.7

5.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

869

2037

4.54

307.65

1.3

u/ml

279.1

252.9

1.49

514

1308

(3048689) Calprotectin [Mass/mass] in Stool

9129

10609

40.61

307.65

7.7

1.4

ug/g

226.8

101.3

111.00

8767

8059

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2676

10611

2.99

307.65

2.7

2.6

22.1

23.9

7.92

2352

9196

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2604

2580

12.82

307.65

1.8

1.6

iu/ml

3.1

10.3

0.53

563

540

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10533

65904

9.84

307.65

18.2

6.9

u/l

74.3

76.2

5.83

10380

62307

(40760892) CBC W Ordered Manual Differential panel - Blood

4659

21091

3.06

307.65

10.6

4.0

—

(3019198) Lymphocytes [#/volume] in Blood

9120

46110

6.07

307.65

14.6

5.7

e9/l

1.9

2.0

14.97

8621

40977

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

235

32.85

307.65

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

894

2175

4.38

307.65

1.2

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

9360

51179

5.83

307.65

16.2

9.0

e9/l

3.9

4.0

11.03

8803

44812

(3025941) Bacteria identified in Stool by Culture

1883

5320

4.05

307.65

1.5

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2740

11509

2.82

307.65

2.7

2.5

g/l

2.4

5.68

2616

10726

(3022948) Iron [Moles/volume] in Serum or Plasma

2902

12525

2.77

307.65

2.8

2.5

umol/l

13.2

13.9

5.08

2788

11713

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

574

164

36.82

307.65

2.1

1.3

au/ml

93.5

181.8

0.84

(3013115) Eosinophils [#/volume] in Blood

9182

46233

6.26

307.65

14.7

6.0

e9/l

0.2

7.85

8650

40980

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1302

133

110.52

307.65

3.5

2.4

mg/l

8.6

6.4

3.50

1097

(3006504) Eosinophils/100 leukocytes in Blood

8422

41758

4.99

307.65

14.5

5.8

2.8

2.9

3.99

8184

39132

(3017143) Hepatitis C virus Ab [Presence] in Serum

3305

13251

3.11

307.65

1.5

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

8464

42914

4.88

307.65

13.9

5.7

57.4

56.6

10.08

8228

40426

(3001604) Monocytes [#/volume] in Blood

9068

44463

6.27

307.65

14.5

5.7

e9/l

0.6

4.01

8510

38753

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1144

137

92.80

307.65

2.9

2.2

au/ml

131.0

219.1

0.95

157

(3022145) Colonoscopy Study observation

7145

8240

21.87

307.65

2.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3813

18465

2.61

307.65

1.6

1.7

—

(3034770) Mitochondria Ab [Titer] in Serum

1190

2495

5.21

307.65

1.7

1.2

titre

520.0

995.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4663

26496

2.29

307.65

4.2

2.5

u/l

58.8

57.3

1.03

4424

24587

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

583

775

7.88

307.65

2.0

1.2

titre

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8149

34478

5.89

307.65

3.9

2.2

nmol/l

74.4

74.5

0.17

7922

31654

(3025159) Blasts/100 leukocytes in Blood

2419

6204

4.69

307.65

6.5

4.2

0.0

0.2

1.12

570

1417

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5397

30510

2.47

307.65

4.9

3.2

u/l

30.0

33.8

5.11

4997

29066

(3017181) Myelocytes/100 leukocytes in Blood

2617

6845

4.67

307.65

6.3

4.1

0.7

0.9

3.24

707

1795

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5389

19513

4.37

307.65

4.0

2.1

mg/l

2.8

0.97

4961

16740

(3021589) Normoblasts [#/volume] in Blood

6943

39699

2.94

307.65

17.2

8.7

e9/l

0.0

2.68

6259

32447

(3019069) Monocytes/100 leukocytes in Blood

8454

41992

5.03

307.65

14.8

6.1

8.7

8.4

15.13

8220

39588

(3013707) Erythrocyte sedimentation rate by Westergren method

9704

65203

4.46

307.65

7.6

3.7

mm/h

11.4

10.3

14.94

9313

60975

(3007566) Smooth muscle Ab [Titer] in Serum

1212

2541

5.22

307.65

1.7

1.2

titre

71.8

129.5

1.51

124

244

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

766

194

42.28

307.65

2.7

1.3

mg/l

9.5

9.0

0.45

650

151

(3002179) Metamyelocytes/100 leukocytes in Blood

2496

6252

4.84

307.65

5.9

3.9

0.3

0.6

8.06

546

1306

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1087

925

12.90

307.65

1.2

1.1

iu/ml

1.8

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6661

40605

2.56

307.65

4.0

2.8

ug/l

98.0

115.6

6.49

6390

38185

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1942

7358

2.98

307.65

3.7

2.3

g/l

0.2

15.31

1850

6859

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

466

708

6.82

292.49

1.5

1.2

titre

264.2

163.1

1.69

173

104

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

465

708

6.81

291.26

1.5

1.2

titre

317.6

150.6

0.74

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

156

49.42

269.79

1.1

1.0

u/ml

36.0

18.5

—

(40758558) Short blood count panel - Blood

3801

22133

2.08

268.19

10.9

6.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1037

3290

3.37

261.86

1.8

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

638

1462

4.57

255.46

1.1

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3328

18971

2.07

244.42

1.7

1.4

g/l

2.5

2.3

3.74

2429

12051

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

644

1541

4.37

243.86

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

744

1990

3.93

242.35

1.4

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

498

980

5.27

238.86

1.7

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

503

999

5.22

238.76

1.7

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

625

1488

4.39

238.14

2.2

1.5

g/l

0.8

0.10

509

1134

(3024522) Salmonella sp identified in Specimen by Organism specific culture

496

977

5.26

237.64

1.7

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4800

31335

1.92

236.77

2.2

1.8

pmol/l

93.5

97.0

6.30

3074

16818

(3048929) Epstein Barr virus Ab [Presence] in Serum

1072

3688

3.11

235.81

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3813

23180

1.97

231.13

1.8

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5636

39066

1.88

228.36

7.0

6.8

mmol/l

1.2

1.91

4737

33103

(3025468) Yersinia sp identified in Specimen by Organism specific culture

482

972

5.14

224.72

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

483

976

5.13

224.66

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

482

979

5.10

222.85

1.7

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

760

2188

3.65

222.14

1.8

1.4

iu/ml

5.1

13.8

2.12

(3019309) Folate [Moles/volume] in Red Blood Cells

2451

12839

2.16

221.98

2.1

1.7

nmol/l

1158.1

1164.9

0.12

1728

9972

(40768797) Stomach Pathology biopsy report

2216

11267

2.20

215.74

1.3

1.2

—

(3032080) INR in Blood by Coagulation assay

4697

31138

1.87

214.87

8.3

7.7

inr

1.1

1.2

11.33

1666

9441

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

868

2789

3.29

213.51

2.0

1.6

titre

529.5

279.8

1.53

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

515

1149

4.65

212.75

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2882

16275

2.03

212.31

2.4

1.6

pmol/l

23295444.5

30279224.6

0.33

2610

13881

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10050

85956

2.53

211.74

20.1

10.8

ml/min/173m2

90.3

87.9

24.22

8865

70529

(3009445) Proteinase 3 Ab [Units/volume] in Serum

984

3507

2.98

202.43

1.8

1.5

u/ml

5.6

15.2

2.59

108

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5126

35377

1.82

202.08

6.2

6.1

mmol/l

1.2

3.98

4729

32361

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

362

681

5.46

182.24

2.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10931

99183

4.14

178.81

22.9

9.1

u/l

27.1

28.0

5.10

10846

96202

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

385

782

5.06

177.72

1.3

1.2

u/l

59.3

63.1

0.34

266

527

(3014765) Yersinia sp identified in Stool by Organism specific culture

762

2528

3.16

176.96

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

765

2544

3.15

176.94

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

756

2504

3.16

176.03

1.3

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

964

3686

2.77

173.21

1.2

1.4

—

(3023368) Bacteria identified in Blood by Culture

3318

20782

1.84

173.21

4.7

4.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

106

35.66

169.31

1.1

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

464

1143

4.19

168.43

4.1

2.9

u/ml

11.1

223.0

1.05

455

1067

(3037467) Urinalysis macro (dipstick) panel - Urine

7592

60584

1.77

167.37

4.7

3.9

—

(40761536) Microorganisms panel - Urine sediment

1547

7502

2.23

165.63

4.2

3.5

—

(3018418) pH of Serum or Plasma

3552

22994

1.79

164.60

4.2

4.1

7.4

0.20

705

4544

(3002385) Erythrocyte distribution width [Ratio]

9298

79219

1.98

162.85

27.2

14.5

13.7

13.5

22.10

9246

77644

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1854

9855

2.05

155.77

4.1

2.8

umol/l

6.4

7.9

3.81

1631

8524

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

708

2458

3.01

151.51

5.3

3.6

u/ml

48.0

2445.3

1.40

630

2105

(40768441) Liver Pathology biopsy report

302

591

5.22

145.36

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1572

8107

2.09

142.31

3.4

2.5

u/l

40.2

45.4

0.36

1410

6974

(3033658) Prothrombin time (PT) actual/Normal

3314

21982

1.72

135.55

5.8

3.9

94.6

92.2

7.44

3230

21437

(3004809) Band form neutrophils/100 leukocytes in Blood

436

1209

3.71

133.85

3.0

3.3

1.0

1.4

2.31

321

947

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3275

21747

1.71

132.91

1.3

u/ml

1.3

1.8

1.38

834

6134

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

250

448

5.68

132.52

1.4

1.2

u/l

77.1

86.9

0.78

208

394

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

244

430

5.78

131.64

1.4

1.2

u/l

20.8

19.6

0.10

204

373

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

438

1252

3.60

128.49

1.1

g/l

1.5

0.27

411

1130

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

295

634

4.75

127.20

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1612

8750

1.98

125.47

1.3

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

294

640

4.69

124.80

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

10203

92126

2.11

119.19

18.5

13.3

mmol/l

139.5

139.7

16.91

9997

89806

(3023103) Potassium [Moles/volume] in Serum or Plasma

10230

92468

2.12

119.05

18.6

13.4

mmol/l

3.9

4.0

55.42

10008

89947

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

123

108

11.50

118.87

2.3

1.6

mg/l

2.1

1.6

1.92

107

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

236

456

5.26

115.19

1.8

1.6

u/l

5.2

5.4

0.07

140

216

(3009261) Glucose [Presence] in Urine by Test strip

5625

43815

1.57

114.14

3.9

3.3

estimate

0.0

0.34

1643

7966

(3035350) Ketones [Presence] in Urine by Test strip

5571

43336

1.56

113.45

3.9

3.2

estimate

0.0

1.54

1637

7991

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

189

300

6.39

113.38

1.7

1.8

u/ml

4922.1

13962.6

0.35

(3029937) Albumin [Presence] in Urine by Test strip

3318

22902

1.64

112.21

4.3

3.6

estimate

0.0

0.44

1648

7946

(3021601) Nitrite [Presence] in Urine by Test strip

5567

43453

1.55

110.53

5.0

4.4

estimate

0.0

1.60

1685

8276

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

278

660

4.29

105.73

1.8

1.4

umol/l

10.9

12.0

2.52

273

625

(3017354) Segmented neutrophils/100 leukocytes in Blood

293

725

4.12

105.49

3.0

3.3

58.2

56.7

0.48

178

465

(3021960) Folate [Moles/volume] in Serum or Plasma

2604

17174

1.67

103.95

1.6

1.5

nmol/l

20.3

20.1

0.17

2346

15004

(3013826) Glucose [Moles/volume] in Serum or Plasma

6172

49778

1.53

102.01

5.2

4.6

mmol/l

6.5

6.6

2.11

5819

46047

(3017732) Neutrophils [#/volume] in Blood

1195

6293

2.01

99.99

2.9

2.7

e9/l

4.2

4.1

0.79

871

5131

(3010375) cycloSPORINE [Mass/volume] in Blood

211

424

5.05

98.49

18.1

27.5

ug/l

130.0

115.7

1.97

192

341

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4481

33993

1.53

96.97

4.0

3.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3431

24604

1.57

95.53

3.6

2.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

227

511

4.51

92.42

1.1

miu/ml

1565.9

1492.7

0.38

227

511

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1460

8432

1.84

91.98

2.2

nmol/l

331.6

371.9

13.80

1358

7775

(3004716) Salmonella sp identified in Stool by Organism specific culture

1016

5221

2.04

90.62

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

604

2516

2.48

89.78

1.2

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1396

8064

1.83

87.61

3.7

2.7

1.8

1.7

1.38

1274

7215

(40761511) CBC panel - Blood by Automated count

10534

98067

2.10

85.11

19.2

11.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

529

2153

2.53

82.53

1.3

1.5

u/ml

22.3

20.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

530

2162

2.52

82.29

1.3

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

248

659

3.83

80.87

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

248

666

3.78

79.66

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1223

7022

1.83

77.72

4.8

4.1

ug/l

16.5

30.0

0.74

956

5561

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

490

1983

2.54

77.32

1.4

1.5

u/ml

106.8

111.6

0.48

101

405

(3006922) Hepatitis E virus Ab [Presence] in Serum

257

723

3.61

77.11

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

268

778

3.50

76.67

3.2

3.9

—

(3008898) HLA-B27 [Presence]

770

3815

2.09

75.38

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

555

2438

2.34

73.10

3.2

3.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

267

5.41

72.55

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

1044

5851

1.86

71.40

2.8

2.7

e9/l

73.9

70.9

1.47

818

4344

(3031040) Bacteria [#/volume] in Urine by Automated count

6669

56720

1.43

70.78

4.5

3.9

e6/l

1007.4

1242.2

0.10

721

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

105

148

7.15

70.47

1.5

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1806

11954

1.61

67.38

2.2

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

375

1424

2.69

67.29

4.9

3.6

u/ml

103.8

532.6

1.60

342

1315

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

384

1491

2.63

65.91

2.6

3.1

u/ml

852.4

1530.5

0.44

(3014576) Chloride [Moles/volume] in Serum or Plasma

1522

9711

1.66

65.70

8.4

7.6

mmol/l

104.8

104.5

2.13

1503

9501

(3002582) Erythrocytes [#/volume] in Urine

3300

25105

1.44

63.01

3.4

3.1

e6/l

62.4

77.2

0.38

2695

19084

(3007461) Platelets [#/volume] in Blood

11010

105619

2.66

61.92

35.0

17.5

e9/l

271.8

253.8

136.28

10932

103210

(3035941) MCH [Entitic mass]

11011

105714

2.64

60.32

34.8

17.4

30.4

30.2

19.11

10974

104508

(3030467) Casts [#/volume] in Urine by Automated count

3040

22924

1.45

60.32

3.3

3.0

e6/l

0.4

0.67

2424

17062

(3024731) MCV [Entitic volume]

11011

105726

2.63

60.09

34.8

17.4

91.3

90.3

90.34

10974

104518

(3026361) Erythrocytes [#/volume] in Blood

11011

105742

2.63

59.77

34.9

17.5

e12/l

4.5

4.6

48.65

10916

103126

(3000850) Epithelial cells [#/volume] in Urine

2393

17263

1.49

59.55

2.7

2.5

e6/l

5.7

0.07

2156

15122

(3010813) Leukocytes [#/volume] in Blood

11012

105774

2.62

59.42

35.0

17.5

e9/l

6.8

6.7

7.17

10920

103121

(3000963) Hemoglobin [Mass/volume] in Blood

11011

105787

2.61

58.89

35.1

17.6

g/l

136.1

137.8

31.07

10972

104568

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

148

342

4.37

58.37

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

148

342

4.37

58.37

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

3480

27076

1.41

57.45

2.8

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1575

10482

1.58

56.54

6.4

6.5

mmol/l

1.0

1.72

1491

9861

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

374

1545

2.47

56.40

1.2

titre

136.0

202.9

—

(36304419) Bacteria [Presence] in Urine

2983

22646

1.43

56.31

3.2

2.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

848

4792

1.83

55.99

1.1

titre

41.0

231.9

—

144

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

167

442

3.82

54.85

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

168

450

3.77

54.24

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4995

41524

1.36

54.19

4.7

3.9

—

(3026782) Osmolality of Urine

2209

15957

1.48

53.86

2.9

2.7

mosm/kgh2o

551.7

555.0

0.26

1959

13622

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

231

764

3.07

53.50

1.1

mg/l

285.2

285.0

0.01

210

690

(3018095) Leukocytes [#/volume] in Urine

3754

29914

1.38

52.66

3.8

3.5

e6/l

66.9

76.1

0.25

2860

20741

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

285

4.46

51.11

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

143

362

3.99

50.02

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

508

2508

2.07

49.88

3.8

4.2

mg/l

1.4

0.47

472

2343

(3032057) Clostridioides difficile [Presence] in Stool

136

6.22

49.52

2.1

2.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

146

381

3.87

48.96

1.1

u/l

22.0

24.4

0.10

124

292

(3009871) Measles virus Ab [Titer] in Serum

140

358

3.95

48.30

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

155

426

3.68

48.24

2.3

1.8

umol/l

2.1

1.9

0.91

148

400

(4035726)

1092

6906

1.64

47.89

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

145

384

3.81

47.63

1.1

u/l

74.9

90.2

0.84

130

304

(3020779) Urea [Moles/volume] in Serum or Plasma

1101

7045

1.62

45.98

8.6

8.3

mmol/l

8.5

8.9

1.23

1049

6762

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1738

12352

1.48

45.10

1.9

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3344

26661

1.36

45.02

3.3

mmol/l

2.3

2.4

3.12

2979

23718

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1825

13123

1.47

44.56

4.3

3.7

mmol/l

0.8

6.61

1699

12365

(3000570) Elastase.pancreatic [Mass/mass] in Stool

470

2356

2.04

44.25

1.5

1.4

ug/g

288.3

279.2

0.41

269

1331

(3019225) pH of Specimen

1133

7380

1.59

43.85

4.0

4.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3670

29815

1.34

43.25

3.3

3.1

ng/l

39.2

69.5

0.90

2207

17735

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2655

20601

1.38

41.81

2.8

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

366

1733

2.15

40.08

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7397

66709

1.32

39.43

4.5

3.0

u/l

50.8

44.6

7.31

7036

63286

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1197

8094

1.54

39.06

3.3

3.1

—

(3020393) Adenovirus Ag [Presence] in Stool

7.10

38.88

1.6

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

123

335

3.70

38.87

3.6

2.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1992

14891

1.41

38.78

1.3

u/ml

7.4

10.7

1.78

763

6141

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

577

3276

1.80

37.23

1.8

g/l

1.4

1.5

0.43

507

2834

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2506

19705

1.35

35.26

1.9

1.8

mg/l

1.1

0.55

1889

14630

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

963

6353

1.56

34.95

3.7

3.8

mmol/l

1.2

0.37

849

5620

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

348

1709

2.07

34.65

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1435

10361

1.44

33.46

1.8

1.7

—

(3002032) Base excess in Venous blood by calculation

1045

7115

1.52

32.76

4.9

4.3

mmol/l

1.5

1.8

1.93

846

5801

(3026008) Bacteria identified in Urine by Culture

2752

22187

1.32

32.09

3.0

2.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

500

2844

1.79

32.04

1.6

1.7

g/l

1.2

0.05

476

2713

(4062490)

229

981

2.36

31.97

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2044

15790

1.36

31.84

1.3

iu/ml

21.4

30.3

2.36

626

4850

(3024139) IgG subclass 3 [Mass/volume] in Serum

229

983

2.36

31.82

1.2

1.3

g/l

0.4

0.13

139

689

(3027135) IgG subclass 1 [Mass/volume] in Serum

229

983

2.36

31.82

1.2

1.3

g/l

7.8

6.6

3.42

142

688

(3028192) IgG subclass 2 [Mass/volume] in Serum

229

984

2.35

31.75

1.2

1.3

g/l

3.2

2.9

1.25

139

692

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

486

2755

1.80

31.50

1.6

1.7

g/l

0.2

1.10

461

2622

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1237

8783

1.46

31.41

3.6

4.5

u/l

223.2

236.9

4.12

1179

8349

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

178

689

2.61

30.89

1.1

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

599

3629

1.69

30.67

1.3

1.2

u/ml

0.3

1.0

3.63

314

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1034

7153

1.49

29.90

5.0

4.3

kpa

5.8

5.9

0.71

1002

6929

(3009542) Hematocrit [Volume Fraction] of Blood

9453

89352

1.35

29.85

22.6

12.7

40.3

40.6

4.55

7088

70374

(3020717) Zinc [Moles/volume] in Serum or Plasma

139

483

2.90

29.68

1.8

1.5

umol/l

22.3

25.5

0.62

132

460

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

487

2813

1.76

29.61

1.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

210

3.97

29.21

1.2

—

(3000494) Fungus identified in Specimen by Culture

1399

10335

1.40

28.37

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1248

9073

1.42

27.69

19.3

20.1

inr

1.2

1.3

1.09

235

1394

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

477

2806

1.73

27.20

2.0

ug/l

5.1

2.2

0.47

429

2505

(3052592) Norovirus Ag [Presence] in Stool

122

4.86

26.84

1.8

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1778

13914

1.33

24.72

2.9

2.6

e6/l

0.9

1.0

0.40

1073

7753

(36660697) Celiac disease serology panel - Serum

1077

7806

1.42

24.16

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

470

2855

1.67

23.82

1.1

u/ml

4.9

5.7

0.11

434

(40768443) Skin Pathology biopsy report

571

3651

1.59

23.56

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1143

8429

1.40

23.16

1.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1132

8342

1.40

23.03

1.8

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1658

13025

1.32

22.23

3.1

2.8

e6/l

2.8

2.6

0.33

957

6893

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

338

1916

1.79

21.97

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

599

3977

1.53

20.94

5.4

4.7

mmol/l

23.8

24.1

1.38

565

3583

(3000991) Gas panel - Venous blood

927

6718

1.41

20.71

9.5

9.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

784

5541

1.45

20.10

4.1

4.2

ng/l

86.6

89.6

0.37

707

4909

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

393

2397

1.66

19.65

2.5

2.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

813

5830

1.43

19.25

4.2

3.6

kpa

4.6

4.7

0.89

785

5626

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

277

1567

1.79

18.19

1.6

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

717

5116

1.43

17.43

7.4

7.7

mmol/l

24.4

24.7

1.29

706

5086

(3034274) Bile acid [Moles/volume] in Serum --fasting

275

1580

1.76

17.15

2.5

2.3

umol/l

12.6

6.3

2.86

213

1162

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7521

70568

1.20

17.12

3.4

3.3

—

(40761535) Cells panel - Urine sediment

867

6415

1.38

17.07

3.5

3.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2544

21650

1.23

17.00

1.7

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

698

4985

1.43

16.88

4.4

3.5

kpa

5.0

5.1

4.84

644

4647

(3004588) Protein electrophoresis panel - Serum or Plasma

666

4718

1.44

16.84

2.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

916

6854

1.37

16.81

3.0

2.5

ml/min/173m2

71.7

71.6

0.02

371

2559

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

313

1883

1.68

16.55

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

489

3273

1.52

16.49

2.1

2.0

—

(3002256) Pathology report gross observation

1374

10942

1.29

16.29

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

174

880

1.99

16.20

1.0

1.1

—

(3009343) pH of Capillary blood

685

4924

1.42

15.98

4.5

3.5

7.4

0.37

100

620

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

239

1348

1.79

15.91

1.8

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

128

584

2.21

15.64

3.0

2.5

94.2

96.9

0.40

122

544

(3013512) EKG study

2577

22122

1.21

15.58

3.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

449

2989

1.52

15.55

2.0

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

296

2.71

15.41

2.0

3.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

917

6957

1.35

15.36

7.5

7.7

mmol/l

1.3

0.35

876

6704

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

235

1338

1.77

15.18

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

342

2161

1.60

14.92

1.2

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

304

1870

1.64

14.79

1.2

1.3

u/ml

6.1

5.1

0.11

134

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

657

4756

1.40

14.72

4.5

3.5

mmol/l

1.4

1.6

0.63

482

3490

(3020630) Protein [Mass/volume] in Serum or Plasma

791

5908

1.36

14.66

2.3

2.5

g/l

67.0

66.8

0.24

743

5472

(3004616) Nuclear Ab [Presence] in Serum

193

1047

1.86

14.62

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

545

3845

1.44

14.11

1.7

2.0

u/l

37.9

39.4

1.07

479

3488

(3051651) Icteric interference index of Serum or Plasma

114

519

2.21

14.06

3.7

3.8

—

(1616796) Gas panel - Central venous blood

293

1811

1.63

14.01

3.1

3.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

194

1069

1.83

14.01

1.7

1.5

—

(3011412) CD3 cells [#/volume] in Blood

175

943

1.87

13.58

1.8

2.6

e9/l

1.1

1.2

0.27

550

(3011397) Hemoglobin [Presence] in Urine by Test strip

2314

19884

1.21

13.57

3.7

3.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

222

1292

1.73

13.34

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

928

7196

1.32

13.34

8.9

8.7

g/l

121.1

123.4

2.62

897

6937

(3012501) Base excess in Blood by calculation

299

1888

1.60

13.13

3.4

3.9

mmol/l

2.4

0.09

200

1243

(3013290) Carbon dioxide [Partial pressure] in Blood

299

1889

1.60

13.10

3.4

3.9

kpa

5.0

0.31

289

1857

(3051611) Lipemic interference index of Serum or Plasma

151

788

1.93

12.94

3.7

3.5

—

(3028433) Virus identified in Specimen by Culture

306

2.53

12.93

1.2

—

(3042733) HLA Ab [Presence] in Serum

368

2.37

12.78

3.0

5.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

250

2.69

12.77

3.1

3.7

50.1

52.1

0.35

243

(3019150) Specific gravity of Urine by Refractometry

2211

19023

1.20

12.68

4.1

3.5

kg/l

1.0

0.24

324

2715

(3010421) pH of Blood

336

2198

1.54

12.67

3.3

3.9

7.4

0.11

289

1858

(3027315) Oxygen [Partial pressure] in Blood

298

1900

1.58

12.58

3.4

3.9

kpa

8.9

8.8

0.58

288

1867

(3026493) Urate [Moles/volume] in Serum or Plasma

2578

22504

1.19

12.57

2.7

2.5

umol/l

3751.4

3501.5

0.13

2328

19939

(3005322) IgE [Units/volume] in Serum or Plasma

826

6354

1.32

12.56

1.3

u/ml

229.6

231.4

0.01

768

5888

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1616

13496

1.23

12.53

3.1

2.9

mmol/l

2.4

1.00

1404

11818

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1493

12373

1.24

12.44

2.4

2.3

29.9

29.7

0.73

1448

12020

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

342

2.41

12.44

2.7

3.6

—

(3016502) Oxygen saturation in Arterial blood

981

7746

1.29

12.30

8.5

8.3

96.5

95.8

3.54

943

7460

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1525

12682

1.23

12.30

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

635

4721

1.37

12.13

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

281

1783

1.59

12.13

3.6

3.0

umol/l

31.5

35.1

2.60

248

1549

(3047181) Lactate [Moles/volume] in Blood

368

2479

1.50

12.12

6.6

6.0

mmol/l

1.3

0.13

322

2175

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.49

12.09

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

254

1581

1.62

11.88

1.1

u/ml

2.0

3.3

2.35

101

840

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

344

2303

1.51

11.68

1.3

u/ml

6.1

5.8

0.04

225

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

348

2337

1.50

11.65

1.3

u/ml

9.7

8.9

0.12

366

(3036071) Salmonella sp Ab [Titer] in Serum

341

2.36

11.60

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

373

2550

1.48

11.44

1.3

u/ml

28.1

37.4

0.32

154

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

179

1027

1.75

11.38

1.5

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

268

1708

1.58

11.38

2.3

2.4

16.8

0.02

134

843

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

158

874

1.82

11.36

1.7

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

115

573

2.02

11.31

1.7

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7421

70482

1.15

11.30

3.7

3.9

pmol/l

14.7

14.6

6.53

6835

65087

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

349

2361

1.49

11.29

3.6

u/ml

0.3

0.23

185

1323

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

202

1206

1.69

11.14

1.5

1.4

—

(3003396) Base excess in Arterial blood by calculation

1073

8686

1.26

10.97

8.1

7.8

mmol/l

0.6

0.9

1.89

834

6770

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

111

553

2.02

10.94

1.5

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2746

24344

1.17

10.85

2.1

u/l

196.0

222.0

0.41

2621

23022

(3026250) Tacrolimus [Mass/volume] in Blood

102

495

2.07

10.80

41.8

36.6

ug/l

7.1

7.5

1.34

457

(3008152) Bicarbonate [Moles/volume] in Arterial blood

619

4670

1.34

10.77

7.2

mmol/l

24.1

24.5

1.75

579

4346

(3027273) Bicarbonate [Moles/volume] in Venous blood

477

3452

1.40

10.77

4.2

3.5

mmol/l

24.8

25.2

1.97

461

3340

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

134

718

1.88

10.69

1.9

2.7

e6/l

433.1

526.0

1.59

116

590

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

399

2802

1.44

10.67

3.1

2.9

g/l

3.4

3.6

1.23

377

2656

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8706

83804

1.17

10.63

4.4

4.5

mu/l

1.7

2.1

5.80

8125

78149

(3015235) Bicarbonate [Moles/volume] in Capillary blood

294

1944

1.53

10.63

4.0

3.1

mmol/l

24.0

24.5

1.41

253

1710

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

133

713

1.88

10.60

1.8

2.8

e6/l

650.4

750.5

0.90

281

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1069

8692

1.25

10.51

8.1

7.8

kpa

5.0

5.1

3.08

1021

8322

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2176

18974

1.18

10.49

2.9

3.0

ng/l

1314.9

1147.9

0.84

1812

15878

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

178

2.82

10.49

3.0

3.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1068

8690

1.25

10.44

8.1

7.8

kpa

12.8

0.08

1021

8319

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

354

2443

1.46

10.39

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

416

2965

1.42

10.27

6.3

5.4

0.9

0.69

393

2770

(3011325) HIV 1+2 Ab [Presence] in Serum

4.54

10.22

1.0

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

420

3009

1.41

10.07

6.2

5.3

1.7

0.41

398

2805

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

125

672

1.87

9.90

1.7

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

125

672

1.87

9.90

1.7

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

125

672

1.87

9.90

1.7

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

604

4600

1.33

9.88

4.1

3.6

g/l

130.6

131.5

0.39

582

4495

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

1426

1.59

9.85

1.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

117

617

1.91

9.84

1.2

u/ml

9.2

10.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

691

5369

1.31

9.80

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

120

643

1.88

9.62

1.2

u/ml

13.0

42.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

206

1287

1.61

9.58

1.8

mmol/l

1.8

1.7

0.43

201

1262

(3028626) Oxygen [Partial pressure] in Capillary blood

280

1875

1.51

9.58

5.4

3.5

kpa

8.7

8.6

0.52

259

1742

(3034860) Kappa light chains.free [Mass/volume] in Serum

302

2054

1.48

9.58

2.9

3.3

mg/l

47.5

80.1

0.61

239

1656

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

438

3190

1.39

9.56

4.7

4.0

47.7

50.4

1.52

432

3149

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

565

4284

1.34

9.53

1.7

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

127

697

1.83

9.45

1.9

2.7

e9/l

0.1

0.2

6.51

115

585

(3022313) Gas panel - Capillary blood

484

3593

1.36

9.39

4.9

3.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

301

2056

1.48

9.35

2.9

3.3

mg/l

36.7

50.8

1.11

237

1660

(3037756) Immunofixation for Serum or Plasma

211

1336

1.59

9.30

1.8

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

375

2673

1.42

9.29

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

293

1997

1.48

9.21

2.9

3.3

ratio

1.4

2.5

0.94

173

(40760888) Immunoglobulin light chains.free panel - Serum

236

1540

1.54

9.13

2.7

3.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

258

2.37

9.09

1.4

1.5

ug/l

10.6

8.8

1.58

258

(3001186) Copper [Moles/volume] in Serum or Plasma

253

2.38

9.01

1.4

1.3

umol/l

16.5

16.8

0.13

218

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

156

2.76

8.77

2.7

2.8

mg/l

67.8

43.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

544

4154

1.33

8.77

2.9

2.6

e6/l

0.4

0.3

0.72

530

4021

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1752

15212

1.18

8.75

3.3

3.5

ng/l

553.7

532.4

0.05

1170

10654

(3019060) Gas panel - Arterial blood

623

4858

1.30

8.62

5.4

5.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

130

2.93

8.62

5.5

ug/min

36.5

42.0

0.29

(3036489) Thrombin time

467

3501

1.35

8.54

2.2

2.3

21.4

21.2

0.30

403

3012

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

415

3055

1.37

8.52

2.4

2.5

93.4

93.1

0.10

388

2837

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

6.37

8.52

1.1

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

419

2.01

8.36

1.1

iu/ml

2.8

3.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

155

2.72

8.31

1.7

1.6

ug/l

0.4

0.39

101

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

424

3158

1.36

8.11

5.0

3.7

mmol/l

24.6

24.7

0.44

398

2949

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

412

2.00

8.02

1.8

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

412

2.00

8.02

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

412

2.00

8.02

1.8

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

413

1.99

7.97

1.8

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

380

2791

1.37

7.94

2.6

2.7

185.2

180.3

0.52

359

2655

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

593

7504

0.78

7.92

1.3

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

616

4882

1.28

7.55

9.7

10.0

94.7

93.9

4.14

609

4871

(3045414) Leukocytes [Presence] in Urine

495

3813

1.31

7.54

1.9

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

542

4231

1.30

7.48

11.5

10.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

1106

1.57

7.41

1.6

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

140

850

1.66

7.41

1.8

2.4

49.6

42.1

1.06

113

(3045424) Erythrocytes [Presence] in Urine

213

1432

1.50

7.26

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.67

7.17

1.2

—

(3003338) MCHC [Mass/volume]

8621

83587

1.13

7.09

28.0

15.0

g/l

332.3

333.6

34.02

8598

82985

(3021901) Oxygen saturation in Capillary blood

204

1367

1.50

7.08

3.8

2.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

333

2442

1.37

7.07

1.8

2.1

mg/l

10.7

0.01

304

2300

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

452

3471

1.31

7.06

3.7

3.2

0.7

0.91

439

3330

(3042631) Mycobacterium sp identified in Specimen

150

939

1.61

7.05

3.1

2.6

—

(3039000) Anion gap in Blood

247

1722

1.44

7.02

8.3

7.2

mmol/l

11.6

11.2

0.98

227

1541

(3018572) Chloride [Moles/volume] in Blood

247

1723

1.44

7.00

8.3

7.2

mmol/l

105.4

105.3

0.21

227

1542

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

195

1302

1.51

6.90

2.5

—

(3024471) HLA-A [Type]

359

1.98

6.88

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

353

2627

1.35

6.85

3.7

4.2

mmol/l

1.4

0.05

342

2587

(3039162) Centromere protein B Ab [Units/volume] in Serum

177

1160

1.53

6.83

1.2

1.3

u/ml

5.3

60.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

304

4119

0.73

6.70

1.5

1.7

mg/l

3.3

3.6

0.53

213

2832

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.98

6.63

2.0

umol/l

1.2

1.3

1.31

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

184

1225

1.51

6.62

1.3

—

(3044889) 12 lead EKG panel

6327

60407

1.11

6.56

3.4

3.3

—

(3003181) Sodium [Moles/volume] in Urine

178

1179

1.52

6.56

1.8

1.4

mmol/l

65.8

65.3

0.05

114

944

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

147

933

1.58

6.55

1.6

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2696

1.34

6.45

2.3

2.2

g/l

4.0

3.8

1.24

257

1974

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2698

1.34

6.42

2.3

2.2

—

(3024932) HLA-DR beta [Type]

355

1.95

6.40

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2700

1.34

6.39

2.3

2.2

g/l

7.1

7.3

0.89

264

2080

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

407

1.87

6.26

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

102

599

1.71

6.19

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1748

15573

1.14

6.07

1.6

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

333

2509

1.34

6.00

2.3

2.2

g/l

10.7

10.2

0.86

282

2158

(3037692) Legionella sp identified in Specimen by Organism specific culture

274

2.05

6.00

1.3

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

379

2912

1.31

5.96

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

598

4861

1.24

5.96

9.8

10.0

0.7

1.37

592

4830

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

235

2.13

5.94

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

161

1069

1.51

5.91

7.1

7.0

mg/l

11.7

11.0

1.16

151

990

(1761482) Bacteria [#/volume] in Urine by Culture

236

1691

1.40

5.84

4.4

3.7

—

(44790047)

147

960

1.54

5.84

1.6

1.5

—

(44790049)

147

960

1.54

5.84

1.6

1.5

—

(44790048)

147

960

1.54

5.84

1.6

1.5

—

(44806118)

147

960

1.54

5.84

1.6

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

217

1540

1.42

5.68

3.4

3.2

—

(3006270) Folate [Moles/volume] in Blood

108

663

1.64

5.59

1.2

1.1

nmol/l

363.0

388.4

0.69

597

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

114

710

1.61

5.57

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

345

1.89

5.55

1.5

2.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

454

1.77

5.52

1.9

1.4

u/ml

16.1

20.1

0.54

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

266

1964

1.36

5.51

1.2

1.3

u/ml

30.8

42.5

0.58

181

(3038515) Glucose [Moles/volume] in Venous blood

195

1366

1.44

5.50

3.7

2.9

mmol/l

7.5

7.4

0.20

190

1334

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

594

4870

1.23

5.49

9.7

9.9

1.3

1.4

2.02

587

4841

(3003740) Influenza virus B Ag [Presence] in Specimen

269

1992

1.36

5.47

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

116

729

1.60

5.47

1.7

1.5

32.1

0.00

453

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

154

1033

1.50

5.43

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

334

2559

1.31

5.40

2.3

2.2

g/l

3.1

0.91

262

2038

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

462

0.30

5.37

3.3

2.3

nmol/l

166.1

148.5

0.38

396

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

118

2.55

5.35

1.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

268

1991

1.35

5.35

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

952

11025

0.85

5.29

1.5

1.7

—

(3003694) ABO and Rh group [Type] in Blood

2998

27784

1.11

5.27

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

410

3238

1.28

5.27

1.5

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

135

890

1.52

5.18

2.6

2.0

mg/l

24.8

25.1

0.02

235

(3008037) Lactate [Moles/volume] in Venous blood

205

1466

1.41

5.18

3.7

2.9

mmol/l

1.5

0.29

200

1427

(3044927) Protein electrophoresis panel - Urine

103

638

1.62

5.17

1.1

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

297

2254

1.33

5.16

3.7

4.4

mmol/l

3.8

3.9

0.64

280

2114

(3017704) Immunofixation for Urine

356

1.83

5.07

1.7

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

616

5116

1.22

5.05

2.3

2.4

u/l

6169.6

5947.9

0.06

207

2047

(3004451) EKG impression Narrative

330

1.85

4.96

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

237

1750

1.36

4.95

2.4

2.2

g/l

131.3

132.2

0.23

183

1273

(1175426) CD3 cells/100 lymphocytes in Blood

118

764

1.55

4.94

1.6

2.2

73.7

73.0

0.22

112

733

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

562

1.64

4.91

2.7

3.0

nmol/l

142.0

105.8

0.31

557

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

127

838

1.52

4.88

1.7

1.8

—

(3049717) Cytology report of Urine Cyto stain

326

2529

1.30

4.85

2.4

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

465

1.70

4.85

1.7

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

142

962

1.48

4.82

1.6

50.8

56.1

0.82

617

(40761539) Cells [Type] in Urine sediment by Light microscopy

208

2.07

4.82

1.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

414

1.74

4.80

1.8

1.5

—

(3020891) Body temperature

381

3020

1.27

4.79

4.8

4.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

605

1.61

4.77

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

209

2.06

4.76

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

275

2091

1.32

4.75

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

439

1.71

4.71

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

300

2312

1.31

4.71

2.4

2.2

g/l

0.8

0.14

263

2043

(3017315) Amylase [Enzymatic activity/volume] in Urine

492

1.67

4.70

1.4

1.3

u/l

331.3

368.6

0.15

451

(3037121) Protein [Mass/volume] in Urine

358

2825

1.28

4.68

3.0

3.4

g/l

0.3

0.54

181

1313

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

205

1494

1.38

4.68

1.1

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

115

751

1.54

4.66

1.6

2.2

10.9

14.1

1.56

393

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

345

1.80

4.63

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.86

4.48

1.5

3.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

423

1.71

4.48

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

718

6120

1.18

4.48

2.4

2.2

ug/l

6.3

7.8

1.38

636

5435

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

222

1652

1.35

4.46

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

222

1652

1.35

4.46

1.5

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

252

1914

1.32

4.41

2.4

2.1

g/l

0.0

1.01

234

1772

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

502

1.64

4.38

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

411

1.71

4.38

1.8

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

272

2091

1.31

4.37

2.3

2.1

g/l

37.6

38.2

0.91

239

1854

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

105

683

1.54

4.36

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

249

1892

1.32

4.36

2.4

2.1

g/l

0.0

0.00

232

1770

(3033705) Calcium.ionized [Moles/volume] in Venous blood

117

783

1.50

4.26

2.7

2.2

—

(3035285) Chloride [Moles/volume] in Venous blood

120

808

1.49

4.25

2.7

2.1

mmol/l

106.3

105.4

1.63

120

798

(3041354) Potassium [Moles/volume] in Venous blood

120

808

1.49

4.25

2.7

2.1

mmol/l

4.0

0.76

120

798

(3034891) Synovial lining cells/100 cells in Synovial fluid

385

1.72

4.24

1.6

1.5

5.5

4.0

0.32

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

400

1.70

4.24

1.4

1.3

titre

54.3

67.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

340

2703

1.27

4.22

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

106

700

1.52

4.13

1.7

2.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

3.75

4.08

1.0

1.2

—

(3048879) Bone marrow aspiration report

188

2.02

4.06

1.6

2.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

268

2080

1.30

4.05

2.4

2.1

g/l

0.0

0.26

250

1932

(3000330) Specific gravity of Urine by Test strip

454

3746

1.22

4.04

3.8

3.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

138

966

1.43

4.03

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

201

1499

1.35

4.02

1.2

—

(3022621) pH of Urine by Test strip

632

5382

1.18

4.01

3.1

2.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

384

1.70

4.01

5.0

6.3

mg/l

5354.7

1082.2

0.56

278

(4198724)

724

0.52

4.00

1.5

2.8

—

(4034850)

350

2813

1.25

3.98

9.8

8.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

260

1.85

3.96

1.6

2.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

466

3864

1.21

3.96

1.1

u/ml

12.6

8.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

199

1487

1.34

3.94

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

209

1577

1.33

3.88

1.3

1.2

u/ml

4.2

4.0

0.10

106

678

(40759836) Histone Ab [Presence] in Serum by Immunoblot

109

736

1.49

3.85

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

109

737

1.48

3.82

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

431

3570

1.22

3.72

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

355

1.69

3.71

1.3

1.2

g/l

0.3

0.64

289

(40765089) Chromosome analysis panel - Blood by G-banded

504

0.46

3.68

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

103

695

1.49

3.67

1.3

1.4

e6/l

220596.8

83704.4

0.65

485

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

109

744

1.47

3.67

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

109

744

1.47

3.67

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

108

736

1.47

3.66

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

155

2.07

3.65

1.7

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

109

745

1.47

3.64

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

512

1.57

3.63

1.2

1.1

u/ml

8.3

19.3

0.55

(3028707) Methadone [Presence] in Urine by Screen method

201

2626

0.76

3.62

1.9

3.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

658

1.49

3.58

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.74

3.58

1.2

1.4

umol/24h

362.9

330.1

0.24

(3021691) Plasmodium malariae Ab [Titer] in Serum

7.78

3.55

2.3

2.9

—

(3021788) Differential panel - Synovial fluid

193

1462

1.33

3.53

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

197

0.25

3.51

1.0

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

118

2.21

3.50

1.2

1.1

pmol/l

5.1

5.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

630

1.50

3.48

1.2

1.1

ratio

1.0

1.1

2.28

224

(3000475) Leukocytes [#/volume] in Synovial fluid

240

1878

1.28

3.46

1.8

1.6

e6/l

8343.1

13449.9

2.71

186

1358

(3016038) Potassium [Moles/volume] in Urine

456

1.58

3.44

1.8

1.2

mmol/l

37.2

35.5

0.17

400

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

244

1.81

3.42

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8606

87719

0.92

3.42

3.6

mmol/l

1.3

3.53

8071

82247

(3009466) Valproate [Moles/volume] in Serum or Plasma

103

1476

0.70

3.38

4.4

5.4

umol/l

335.8

370.6

1.56

1284

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

321

1.69

3.32

4.6

3.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

269

1.75

3.30

1.3

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

574

1.50

3.27

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

198

1524

1.30

3.26

1.5

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

248

1.78

3.26

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

323

1.68

3.25

1.5

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

204

1579

1.30

3.23

1.5

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

324

1.67

3.22

1.2

107.1

110.4

0.48

289

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

121

866

1.40

3.20

1.7

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

157

1.98

3.18

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

546

1.51

3.17

1.5

ug/l

7.9

7.1

0.18

487

(3013293) Extractable nuclear Ab [Presence] in Serum

137

2.05

3.15

1.5

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

251

1.76

3.14

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

596

1.48

3.13

1.5

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

105

736

1.43

3.13

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

101

703

1.44

3.13

1.7

2.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

131

2.06

3.11

1.3

1.6

nmol/l

8.5

346796.1

1.08

109

(3015183) Erythrocyte sedimentation rate

589

1.48

3.11

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

252

1.75

3.11

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

688

1.44

3.10

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

207

1618

1.28

3.06

1.3

1.2

u/ml

5.2

3.3

0.84

525

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

106

2.17

3.02

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

114

2.11

2.93

1.9

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

358

1.60

2.88

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

107

766

1.40

2.87

1.3

mmol/l

1.9

2.0

0.10

102

715

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1067

9666

1.11

2.84

7.3

6.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

439

1.53

2.83

1.2

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9107

92438

0.92

2.80

4.3

mmol/l

2.7

2.8

17.72

8542

86758

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

452

3872

1.17

2.78

2.3

—

(4306422)

202

1596

1.27

2.78

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

333

2778

1.20

2.77

2.1

2.4

ug/l

227.5

647.3

2.92

298

2595

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

145

1.93

2.74

1.3

1.2

ng/l

33.1

75.8

1.15

(3006653) Thiamine [Moles/volume] in Blood

459

1.51

2.73

1.2

1.3

nmol/l

143.1

134.7

0.78

459

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1420

15390

0.91

2.72

2.7

ug/l

0.7

0.90

886

9247

(21494434) Karyotype in Bone marrow

640

1.43

2.72

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

233

1.72

2.70

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

177

1381

1.29

2.70

2.0

1.7

—

(3023419) Bacteria identified in Sputum by Culture

124

921

1.35

2.68

3.0

2.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

326

1.60

2.67

1.9

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

326

1.60

2.67

1.9

2.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

227

1.72

2.65

1.3

nmol/l

117.4

116.6

0.01

167

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

652

5767

1.14

2.61

2.8

ng/l

184.6

162.8

0.56

582

5157

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

229

1.71

2.58

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

330

1.58

2.55

2.0

2.3

—

(3026726) Creatinine [Moles/volume] in Specimen

2.35

2.55

1.4

2.7

umol/l

542.9

211.0

0.51

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

192

1526

1.26

2.55

1.1

126.1

115.6

4.41

175

1394

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

739

0.63

2.54

10.2

11.9

mmol/l

0.6

0.36

677

(3000764) Benzodiazepines [Presence] in Urine

545

6209

0.87

2.54

1.6

2.2

—

(3000012) Reticulocyte production index

371

1.54

2.52

1.3

1.5

—

(3016750) Collection duration of Urine

460

1.48

2.51

2.5

2.2

min

516.0

498.5

0.79

360

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

124

932

1.33

2.51

3.1

3.2

nmol/l

9.3

10.3

0.05

118

906

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

609

1.42

2.50

1.6

1.8

mg/l

3.6

3.9

0.20

586

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

135

1028

1.32

2.50

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

552

1.43

2.48

1.3

1.5

u/l

5.4

6.3

1.07

471

(1761868) Lipid panel - Serum or Plasma

3529

36823

0.94

2.46

2.6

2.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

123

1.95

2.44

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

293

2449

1.20

2.43

1.4

1.3

mg/l

507.3

505.1

0.02

284

2330

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

621

1.40

2.43

1.1

iu/ml

9.2

8.9

0.02

168

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

145

1121

1.30

2.41

1.1

94.8

96.9

0.47

137

1055

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

124

1.94

2.39

1.1

—

(4015189)

175

1.77

2.37

1.8

2.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8953

90799

0.93

2.36

4.0

3.9

mmol/l

1.4

0.17

8430

85461

(3029075) Extractable nuclear Ab panel - Serum

282

1.60

2.35

1.1

—

(4268621)

144

1117

1.29

2.35

2.4

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

314

1.56

2.34

2.4

—

(3027944) Amphetamines [Presence] in Urine

545

6163

0.88

2.30

1.5

2.1

—

(3011985) Renin [Units/volume] in Plasma

150

1175

1.28

2.28

1.5

1.6

mu/l

73.8

62.0

0.35

132

1062

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1606

14997

1.08

2.28

2.1

—

(4010399)

673

6025

1.12

2.26

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

258

2149

1.21

2.25

1.3

mmol/l

3.7

0.02

242

2018

(3028300) Cannabinoids [Presence] in Urine

556

6262

0.88

2.22

1.6

2.2

—

(3027008) Opiates [Presence] in Urine

555

6249

0.88

2.20

1.5

2.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

200

1629

1.23

2.19

1.2

1.1

au/ml

10.7

11.3

—

118

(3014271) Vancomycin [Susceptibility]

281

1.57

2.15

2.8

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.26

2.07

1.7

2.9

pmol/l

3870.4

70.1

—

(3051339) Copper [Moles/volume] in Blood

2.26

2.07

1.1

1.2

umol/l

16.3

16.4

0.04

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

2.06

0.0

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

468

4126

1.14

2.04

11.1

10.2

mmol/l

23.7

24.2

2.99

441

3878

(3010937) Rubella virus Ab [Presence] in Serum

2.11

2.02

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

1206

12979

0.92

2.00

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.96

1.99

1.1

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

139

1100

1.27

1.99

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

418

1.44

1.98

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

232

1.60

1.98

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

488

0.61

1.96

3.9

3.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

503

1.39

1.95

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.35

1.94

1.5

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

487

0.61

1.94

7.9

6.5

—

(40768446) Kidney Pathology biopsy report

420

1.43

1.93

1.8

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

193

1590

1.22

1.93

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.96

1.93

1.6

1.2

—

(3016879) Cocaine [Presence] in Urine

516

5780

0.89

1.92

1.6

2.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

515

1.38

1.88

1.3

42.0

69.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.16

1.87

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

301

3489

0.86

1.87

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

300

3478

0.86

1.87

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

567

1.36

1.87

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

302

3499

0.86

1.87

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

516

1.38

1.86

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.65

1.86

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

153

1237

1.24

1.85

1.3

nmol/l

0.2

0.16

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.94

1.84

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

3.53

1.83

1.0

u/field

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

285

1.51

1.83

5.2

6.6

mmol/l

24.3

24.9

0.32

269

(3043238) Trisomy 21 risk [Likelihood] in Fetus

246

2892

0.85

1.83

1.5

—

(3012516) Albumin [Mass/volume] in Urine

2364

22547

1.06

1.83

3.4

mg/l

464.9

415.6

0.19

1619

14670

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

303

3500

0.86

1.81

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

148

1198

1.24

1.78

1.5

1.7

—

(3024928) Oxygen saturation in Venous blood

208

1743

1.20

1.78

4.2

3.8

—

(3005033) Fetal Nuchal fold Thickness US

240

2816

0.85

1.76

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

101

782

1.29

1.76

1.4

1.3

nmol/l

1.5

1.4

0.39

700

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.33

1.74

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.33

1.74

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.33

1.74

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.33

1.74

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.33

1.74

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.33

1.74

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.33

1.74

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

241

2824

0.85

1.74

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1746

16523

1.07

1.74

2.2

—

(4281824)

814

0.72

1.72

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.67

1.72

1.5

1.1

—

(40768800) Prostate Pathology biopsy report

114

1435

0.79

1.72

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

388

4387

0.88

1.72

1.5

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

500

1.36

1.69

1.9

1.7

147.1

138.3

0.36

470

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

736

1.29

1.66

2.3

2.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

297

2581

1.15

1.65

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

112

1.79

1.64

1.2

1.4

68.0

57.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

119

1480

0.80

1.63

1.4

1.3

mmol/l

7.0

0.08

1089

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

427

1.38

1.63

1.3

1.6

u/field

1.6

3.2

1.79

314

(43055514) Macroprolactin [Presence] in Serum or Plasma

341

0.59

1.62

1.4

—

(3022475) Manganese [Moles/volume] in Blood

2.06

1.59

1.2

1.3

—

(40768806) Pleura Pathology biopsy report

674

0.71

1.58

1.5

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2015

21113

0.94

1.56

3.8

3.7

21.3

21.8

0.70

904

8963

(1001926) Buprenorphine [Presence] in Urine by Screen method

430

4796

0.89

1.55

1.6

2.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.11

1.54

1.0

1.2

—

(4024509)

683

1.29

1.54

1.6

1.5

—

(3003129) Base excess in Capillary blood by calculation

176

1.59

1.54

1.6

1.8

mmol/l

-1.3

0.9

1.41

166

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

250

2161

1.16

1.52

1.5

1.4

e6/l

63.7

25.4

0.38

191

1657

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

250

2162

1.16

1.51

1.6

1.5

e6/l

933.6

2943.7

0.60

203

1751

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

193

1.56

1.50

1.3

1.2

pmol/l

205.6

290.3

1.33

141

(3044290) Cell count panel - Cerebral spinal fluid

236

2035

1.16

1.49

1.5

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.95

1.48

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

487

1.34

1.47

1.8

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

557

1.31

1.46

1.5

1.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

326

1.41

1.46

1.2

g/l

—

0.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

294

1.43

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2457

23621

1.05

1.42

4.3

4.1

mg/mmol

8.8

9.9

0.57

1673

15491

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.79

1.42

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

105

843

1.25

1.42

1.2

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

328

1.40

1.42

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

482

1.33

1.41

1.4

1.7

nmol/l

1.2

0.07

377

(3004775) Volume in Urine collected for unspecified duration

613

1.29

1.41

2.4

2.3

788.7

641.8

1.66

439

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.25

1.40

2.4

2.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1529

14524

1.06

1.38

1.7

1.8

1.4

0.95

1334

13025

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.00

1.37

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

476

1.33

1.37

1.1

1.0

97.3

95.8

0.13

391

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.61

1.36

1.0

—

(3000492) Spirometry study

1051

9867

1.07

1.36

1.5

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.75

1.34

1.0

1.2

—

(40768795) Lymph node Pathology biopsy report

101

815

1.24

1.33

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

674

0.74

1.33

1.4

1.5

e6/l

15743.5

62738.8

2.61

394

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.04

1.32

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

226

1966

1.15

1.31

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

692

1.26

1.30

1.2

1.3

u/ml

0.4

1.2

1.05

293

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

148

1753

0.84

1.30

1.2

1.3

ug/l

2.3

3.8

4.70

138

1594

(3030313) Adrenal Ab [Titer] in Serum

106

1.70

1.29

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.76

1.28

1.5

1.6

mg/l

3.9

1.6

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.76

1.28

1.5

1.6

mg/l

3.3

4.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.76

1.28

1.5

1.6

mg/l

1.3

1.9

0.32

(3014051) Protein [Presence] in Urine by Test strip

216

1876

1.15

1.28

2.3

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

335

3741

0.89

1.28

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

145

1.59

1.28

1.7

2.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.89

1.28

2.0

5.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

353

1.36

1.26

1.1

1.2

114.8

107.1

0.72

322

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

715

6641

1.08

1.25

2.3

au/ml

24.6

21.8

0.24

439

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

696

1.25

3.6

3.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

242

0.58

1.25

1.4

1.2

—

(3024263) Appearance of Synovial fluid

423

1.33

1.24

1.9

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

116

0.43

1.24

1.2

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

179

1.51

1.23

2.9

4.4

u/l

89.1

77.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

338

1.36

1.22

1.2

99.2

89.2

1.11

158

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.97

1.22

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.31

1.18

1.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

349

1.35

1.18

1.1

100.2

90.6

2.24

159

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9054

91352

0.96

1.18

4.1

4.0

mmol/l

4.6

4.7

14.64

8558

86288

(3045788) Cell count panel - Pleural fluid

591

0.74

1.17

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

625

0.75

1.17

1.9

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

640

1.25

1.17

2.3

2.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

198

1.47

1.16

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

132

1114

1.19

1.15

1.4

pmol/l

326.8

316.4

0.10

106

860

(3009508) Creatinine [Moles/volume] in Urine

2694

26087

1.04

1.15

3.3

mmol/l

8.3

8.2

0.57

2330

22403

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

669

1.24

1.14

2.5

3.1

—

24.6

—

(3019977) pH of Arterial blood

412

1.31

1.14

2.7

2.9

7.4

0.27

130

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

118

1.61

1.14

1.8

2.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

220

1934

1.14

1.13

1.4

1.5

pmol/l

59.5

123.6

6.17

214

1884

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

657

6115

1.08

1.12

1.3

au/ml

59.9

47.4

0.57

243

(40765096) Chromosome analysis panel by Banding

233

1.42

1.12

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

755

0.78

1.12

1.2

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.96

1.11

5.4

5.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

195

0.56

1.10

1.9

2.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

741

0.78

1.09

1.7

2.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

311

1.35

1.09

1.0

1.2

58.7

15.6

—

(3016135) IgD [Mass/volume] in Serum

2.38

1.09

1.0

1.2

mg/l

36.6

70.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.38

1.09

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

193

1.45

1.08

1.3

1.2

g/l

37.4

39.8

0.56

110

(3046861) Legionella sp Ag [Presence] in Urine

2.19

1.08

1.4

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

437

4009

1.09

1.07

1.3

miu/ml

225.3

223.1

0.04

177

1882

(3039443) Prostate specific Ag panel - Serum or Plasma

171

1964

0.87

1.06

1.5

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

296

2665

1.11

1.05

1.9

pmol/l

204.1

201.3

0.18

284

2543

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.71

1.05

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

220

1.41

1.04

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

220

1.41

1.04

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

220

1.41

1.04

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

212

1.42

1.03

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

212

1.42

1.03

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

212

1.42

1.03

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

212

1.42

1.03

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.83

1.02

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

130

1.54

1.02

1.1

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

103

862

1.20

1.01

6.0

13.4

mmol/l

6.8

7.4

0.83

723

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.77

1.00

1.1

u/l

28.7

10.1

0.39

(3036603) Volume of Urine

546

1.25

1.00

1.8

1.7

1701.8

2121.2

0.84

110

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

448

1.27

1.00

1.6

2.1

umol/l

79.0

146.0

2.49

224

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

231

1.39

0.99

1.2

77.7

82.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

206

1.41

0.98

1.4

1.3

42.9

36.8

0.44

133

(3049242) von Willebrand panel - Platelet poor plasma

2.17

0.98

1.6

1.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

6.2

—

0.2

—

(3011288) Drugs identified in Urine by Screen method

379

4130

0.91

0.96

2.0

3.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

730

1.21

0.96

1.0

1.1

u/ml

4.1

2.2

0.26

201

(1617658) Protocol used for examination of sentinel lymph nodes

536

0.76

0.95

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

577

1.23

0.95

1.8

2.8

36.1

40.4

0.59

201

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

141

1624

0.87

0.94

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.77

0.94

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

382

1.28

0.93

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

108

917

1.18

0.93

1.4

mmol/l

10.7

11.8

0.64

211

(3023199) Leukocytes [#/volume] in Pleural fluid

756

0.81

0.92

1.4

1.5

e6/l

2685.7

2558.7

0.08

541

(3044941) Cell count panel - Synovial fluid

142

1233

1.15

0.92

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.73

0.92

1.4

1.7

umol/l

39.0

42.5

—

(4211845)

436

1.26

0.92

2.9

2.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

330

1.30

0.92

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

330

1.30

0.92

1.6

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

136

1178

1.16

0.91

1.6

—

(3036180) Methadone [Presence] in Urine

2.14

0.91

1.0

2.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

103

1.55

0.87

2.4

2.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.86

0.87

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

342

1.29

0.87

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.00

0.87

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

212

1.37

0.86

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

343

1.28

0.85

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

390

0.74

0.84

1.9

2.1

ug/min

82.8

172.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

110

945

1.17

0.84

3.1

2.9

nmol/l

0.8

0.00

695

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

251

0.68

0.84

1.8

2.1

umol/l

16.8

16.2

0.07

251

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

451

1.24

0.84

2.0

2.5

ug/l

25.1

131.2

0.94

424

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

111

0.54

0.83

1.2

3.3

umol/l

27.8

41.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

940

0.84

0.82

1.8

2.2

nmol/l

21.4

20.3

0.50

896

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

0.82

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

622

6595

0.94

0.81

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2337

22731

1.04

0.80

1.7

1.6

mmol/l

1.4

0.39

1995

19490

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

232

1.34

0.80

1.2

72.0

75.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

189

1.38

0.80

1.2

1.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.82

0.79

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

546

1.21

0.78

1.1

nmol/l

1.3

8.2

1.30

106

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

316

0.73

0.78

1.9

2.9

umol/l

27.6

28.3

0.11

231

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

367

3400

1.08

0.78

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

597

5628

1.06

0.78

1.4

iu/l

26.3

25.2

0.33

521

4802

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.62

0.78

1.3

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.59

0.78

1.3

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

199

1.36

0.78

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

199

1.36

0.78

9.9

5.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

100

0.50

0.77

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

210

0.67

0.76

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

115

1.48

0.76

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

124

1088

1.14

0.74

1.6

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

116

1.47

0.74

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.84

0.73

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

172

0.64

0.73

1.2

1.7

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.00

0.72

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

103

894

1.15

0.72

4.0

4.8

u/ml

62.0

70.6

0.14

281

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.80

0.72

2.1

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.31

0.72

2.4

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

237

1.31

0.72

2.4

3.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.47

0.70

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

164

1472

1.12

0.70

1.2

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

143

1.40

0.70

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

169

1.36

0.69

1.1

1.7

ug/l

1.2

2.1

2.74

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

146

1304

1.12

0.68

1.2

1.3

u/l

43.7

36.2

0.19

134

1137

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.67

0.68

1.0

1.1

u/l

204.6

530.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

102

890

1.15

0.68

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

833

0.85

0.67

1.4

1.5

g/l

34.1

34.2

0.01

750

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

121

0.58

0.67

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.63

0.66

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

818

1.15

0.66

1.3

1.5

mosm/kgh2o

278.6

282.2

0.70

632

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

421

1.21

0.65

1.8

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.54

0.65

1.4

1.3

—

(3034426) Prothrombin time (PT)

376

1.22

0.65

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

894

0.86

0.64

1.5

—

(3020491) Glucose [Moles/volume] in Blood

689

1.16

0.64

1.7

1.8

mmol/l

6.9

6.4

0.75

511

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

377

1.22

0.63

1.2

1.1

ng/l

108.4

280.0

0.85

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

323

1.24

0.63

2.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

131

0.61

0.63

1.4

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.49

0.63

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

165

0.67

0.62

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

138

1.38

0.62

1.0

1.1

u/ml

0.0

0.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

103

0.58

0.62

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

128

1144

1.12

0.61

1.1

—

13.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

103

910

1.13

0.60

1.0

1.1

mg/l

224.1

253.9

1.55

811

(3016330) Potassium [Moles/time] in 24 hour Urine

122

1.39

0.60

1.3

1.4

—

97.6

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.59

0.0

1.2

—

27.6

—

(3020650) Glucose [Presence] in Urine

281

1.25

0.59

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.53

0.59

2.3

2.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

131

1.37

0.59

6.1

6.8

—

(3006462) Nitrate [Presence] in Urine

400

1.20

0.58

2.9

2.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

753

1.14

0.57

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

548

1.17

0.57

5.6

6.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

456

1.19

0.57

1.0

ng/l

314.7

310.6

0.04

334

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

375

0.80

0.56

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

229

1.27

0.56

1.8

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.56

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1010

9755

1.04

0.55

3.9

4.0

32.6

31.5

2.31

777

7002

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

171

1563

1.10

0.55

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

440

1.18

0.54

1.8

2.4

14.0

10.1

1.61

416

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.58

0.54

1.0

1.3

nmol/l

450.5

520.3

—

(40758292) HTLV I+II Ab panel - Serum

186

1.29

0.54

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

622

5952

1.05

0.53

3.3

3.4

pmol/l

4.5

4.6

0.17

557

5353

(3037556) Urate [Mass/volume] in Serum or Plasma

231

1.26

0.53

1.1

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

437

4606

0.95

0.53

1.5

1.7

mu/l

281.0

297.6

0.59

395

4174

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.43

0.52

2.1

1.9

—

(3002619) Bacteria identified in Specimen by Culture

170

1.29

0.51

1.5

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

725

1.13

0.50

1.3

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.49

0.49

1.2

1.1

—

2.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

101

1.39

0.49

1.2

mmol/l

0.7

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

165

1519

1.09

0.48

1.3

1.6

—

(40757373) Influenza virus identified in Isolate

154

1.30

0.48

1.3

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8648

86939

0.98

0.48

4.0

mmol/l

5.8

0.74

8026

80800

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

196

1819

1.08

0.47

1.7

2.3

nmol/l

1.0

0.8

1.48

167

1545

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.46

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.46

0.46

1.0

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

457

1.16

0.46

1.0

ng/l

770.7

755.3

0.10

327

(3008536) Aspergillus sp Ab [Presence] in Serum

173

1.27

0.46

2.2

2.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

182

1.26

0.46

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.62

0.45

1.4

1.2

umol/24h

1.6

1.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.43

0.45

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

949

0.89

0.45

1.8

1.5

promille

1.1

1.4

0.88

712

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

459

1.16

0.44

1.0

ng/l

36.7

42.4

0.55

329

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.40

0.44

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

582

1.13

0.44

1.9

u/field

1.4

1.8

0.72

261

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

104

943

1.10

0.43

1.1

1.2

mg/l

39.4

41.0

0.15

793

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

230

0.78

0.43

1.1

u/ml

0.1

6.2

1.78

172

(4027681)

734

1.12

0.43

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

892

9195

0.97

0.42

2.1

2.0

—

(3012441) Differential panel - Pleural fluid

660

0.88

0.42

1.4

1.5

—

(44806420)

162

0.74

0.42

2.4

2.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

122

1.31

0.42

8.7

10.5

mmol/l

5.4

5.7

0.14

122

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

369

1.17

0.41

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

369

1.17

0.41

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

158

1.27

0.41

2.0

2.1

mmol/l

9.4

7.8

0.60

(3002331) Protein [Mass/volume] in Peritoneal fluid

167

1.26

0.41

1.0

1.5

g/l

26.4

24.6

0.19

125

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.38

0.41

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

10263.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.41

0.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

150

0.73

0.41

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

520

0.86

0.41

5.0

6.8

u/ml

30.7

6005.1

—

124

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

283

0.81

0.41

1.7

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

572

5938

0.96

0.41

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

277

1.19

0.41

3.2

8.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.36

0.41

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.40

0.0

1.8

—

8.1

—

(3042517) Benzodiazepines panel - Urine

177

1.24

0.40

1.7

2.7

—

(3000060) B lymphocytes [#/volume] in Blood

324

1.17

0.40

1.7

2.3

e6/l

261.3

256.8

0.02

169

(3033923) Metanephrine [Moles/time] in 24 hour Urine

160

1.25

0.38

1.3

1.1

umol/24h

0.6

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

116

0.69

0.36

4.5

6.7

—

(3022689) Creatine [Moles/volume] in Urine

267

0.82

0.36

2.5

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.43

0.35

2.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

153

1.24

0.35

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

297

3112

0.95

0.34

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

881

1.09

0.34

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.34

0.34

1.0

u/ml

0.1

0.9

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

200

1.20

0.33

1.2

1.5

g/l

12.0

13.1

0.17

148

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

118

1.27

0.33

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1311

13372

0.98

0.32

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

686

7057

0.97

0.32

1.2

iu/ml

88.1

145.4

5.55

238

2720

(3008116) Ketones [Moles/volume] in Urine by Test strip

198

0.81

0.32

1.6

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

100

1081

0.92

0.31

1.3

pmol/l

81.3

99.9

0.24

306

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

977

0.92

0.31

1.5

1.6

mmol/l

7.4

7.7

0.51

595

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1092

11155

0.98

0.31

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

695

0.91

0.31

2.7

3.5

mu/l

38.2

30.5

0.57

655

(3012494) Peanut IgE Ab [Units/volume] in Serum

334

1.14

0.30

1.0

1.1

u/ml

0.3

6.0

1.61

192

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

130

0.77

0.29

1.0

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

185

1.19

0.29

1.3

mu/l

40.0

96.3

0.80

150

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.29

0.28

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

399

3857

1.04

0.28

1.7

1.8

nmol/l

39.2

39.1

0.02

391

3769

(3001893) Eosinophils/100 leukocytes in Pleural fluid

186

1.18

0.27

1.3

1.5

4.5

3.0

0.24

163

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.23

0.27

1.6

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

172

1811

0.95

0.27

4.3

3.2

mg/l

22.0

26.3

1.19

106

1122

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

358

3457

1.04

0.27

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.19

0.26

1.1

1.2

mg/l

6.2

11.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

169

1.18

0.25

1.3

1.2

ug/l

12.7

183.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

742

1.08

0.25

1.0

1.1

u/ml

0.9

2.5

1.13

184

(3023487) Leukocytes [#/volume] in Peritoneal fluid

276

0.87

0.24

2.1

2.2

e6/l

803.8

3605.2

0.51

195

(3017446) Testosterone [Moles/volume] in Serum or Plasma

868

8512

1.02

0.24

2.2

nmol/l

13.1

13.0

0.18

795

7661

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

558

0.91

0.23

1.4

mmol/l

5.3

5.5

0.83

529

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

199

1.16

0.23

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

394

3828

1.03

0.22

1.4

u/l

8.3

8.6

0.21

325

3135

(3005011) Chlamydia sp Ab [Titer] in Serum

153

1.18

0.22

1.7

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

1.27

0.22

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

1020

0.94

0.22

1.9

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.22

0.22

10.2

10.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

238

2468

0.96

0.21

1.1

u/ml

1.6

1.7

0.07

1045

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

229

1.14

0.21

1.3

1.5

38.3

62.5

2.66

190

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.19

0.21

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.19

0.21

1.0

1.3

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

172.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

607

6203

0.98

0.21

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

135

1.19

0.21

11.8

7.2

60.3

70.6

0.61

109

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

215

2232

0.96

0.21

1.1

u/ml

7.4

6.5

0.28

1224

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(4038314)

134

0.82

0.20

1.2

—

(4094501)

238

2299

1.04

0.20

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

473

1.08

0.18

1.1

u/ml

29.8

9.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.21

0.18

1.3

2.0

—

(3019174) dRVVT (LA screen)

100

1.20

0.18

1.0

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

147

1.16

0.18

2.5

1.6

ng/l

110.7

128.9

0.24

147

(44806071)

147

1.16

0.18

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

160

1663

0.96

0.18

1.1

u/ml

7.6

5.3

0.56

714

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8118

81397

0.99

0.17

5.1

5.0

mmol/mol

38.5

38.9

3.56

7639

76554

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

341

0.91

0.17

1.5

pmol/l

14.7

14.9

0.08

290

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.11

0.17

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.74

0.17

1.2

u/ml

1.6

5.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

718

7294

0.98

0.16

1.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

245

0.90

0.15

2.1

2.0

e6/l

7364.1

15296.1

0.40

134

(44813793)

721

1.05

0.15

1.1

—

(3025315) Body weight

1.13

0.15

6.1

3.7

—

(3033799) Differential panel - Peritoneal fluid

236

1.10

0.14

2.2

2.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

566

1.06

0.14

1.6

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

217

1.11

0.14

8.8

7.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

275

0.91

0.14

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

160

0.87

0.14

7.5

7.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

357

0.92

0.14

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

206

2116

0.97

0.13

1.1

u/ml

2.9

2.4

0.18

543

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

209

1.10

0.13

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

200

0.90

0.12

9.2

7.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2642

26570

0.99

0.12

4.2

ug/l

2.1

2.7

1.88

2399

24136

(4133840)

313

0.93

0.12

1.3

1.1

—

(40768793) Breast Pathology biopsy report

167

1714

0.97

0.11

1.4

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

136

0.88

0.11

1.0

u/ml

1.0

0.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

183

1874

0.98

0.10

1.4

1.5

nmol/l

0.4

0.04

150

1503

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

202

1.09

0.10

1.3

1.7

—

(3044007) Cell count panel - Peritoneal fluid

218

0.92

0.10

2.5

2.1

—

(3045716) Anion gap in Serum or Plasma

339

1.06

0.10

3.0

2.5

mmol/l

8.4

9.3

0.72

255

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

634

1.04

0.09

1.3

umol/l

3.4

5.6

6.54

591

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.09

0.09

1.2

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

235

2309

1.02

0.09

1.9

iu/l

3.4

4.4

1.58

882

(3000034) Microalbumin [Mass/volume] in Urine

764

1.03

0.08

3.5

3.0

mg/l

44.3

67.4

0.46

564

(3001729) Color of Synovial fluid

1.03

0.08

1.5

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.83

0.08

1.4

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

176

1795

0.98

0.08

1.1

u/ml

3.0

4.7

1.12

733

(3017569) Oxygen content in Arterial blood

322

1.06

0.08

2.9

2.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.03

0.07

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.86

0.07

1.8

5.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.86

0.07

2.1

2.3

u/field

0.0

0.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.87

0.07

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

353

1.05

0.07

3.3

2.9

—

(3014891) Appearance of Pleural fluid

0.84

0.07

2.0

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

748

1.03

0.07

1.5

2.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.02

0.07

1.3

u/l

26.6

488.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

423

4193

1.01

0.05

2.1

3.1

u/ml

44.0

42.4

0.05

408

4058

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

178

1756

1.01

0.05

1.4

u/l

23.6

23.0

0.10

151

1454

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

244

2413

1.01

0.05

1.5

—

(3035880) pH of Pleural fluid

343

0.96

0.04

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

130

0.92

0.04

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

145

1469

0.99

0.04

1.0

1.1

u/ml

0.6

0.5

0.04

336

(1002224) Polysomnography panel

476

4731

1.01

0.04

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

378

1.03

0.04

1.1

u/ml

14.0

10.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

442

0.97

0.03

1.5

1.6

nmol/l

3.6

9.5

0.52

362

(3008401) Mugwort IgE Ab [Units/volume] in Serum

211

2129

0.99

0.03

1.1

u/ml

1.7

1.4

0.14

947

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

284

2860

0.99

0.03

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

108

0.93

0.03

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

360

1.03

0.03

3.0

2.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

170

1715

0.99

0.02

2.1

2.2

titre

13.0

7.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

158

0.95

0.02

1.0

1.2

mg/l

0.3

83.4

—

116

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

424

4254

1.00

0.01

2.0

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

176

1749

1.01

0.01

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

137

0.95

0.01

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

137

0.95

0.01

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

532

1.02

0.01

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

205

2059

1.00

0.01

1.8

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

387

0.98

0.01

2.1

2.0

ug/l

2.0

3.4

1.65

339

(40757494) Bilirubin.total [Moles/volume] in Blood

437

0.98

0.01

2.3

2.5

umol/l

12.3

19.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

697

0.99

0.01

1.0

u/ml

0.2

1.4

—

103

(3044009) aPTT.lupus sensitive (LA screen)

1.06

0.01

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

105

1043

1.01

0.00

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

141

1417

0.99

0.00

1.8

1.9

titre

8032.0

2398.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

236

0.97

0.00

1.4

2.5

ng/l

126.1

122.4

0.05

139

(4146454)

754

1.01

0.00

2.4

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

162

1626

1.00

0.00

1.1

iu/ml

25.4

6644.3

0.65

408

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

193

1924

1.00

0.00

2.8

2.5

ug/min

78.0

120.8

1.06

115

1239

(3001556) Androgen free Index in Serum or Plasma

166

1.02

0.00

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

184

0.98

0.00

1.7

1.5

nmol/l

0.2

0.00

139

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

625

0.99

0.00

1.1

u/l

1.0

0.22

285

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

112

0.98

0.00

3.2

3.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.01

0.00

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

189

1.01

0.00

1.1

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.93

0.00

1.4

3.1

—

0.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.93

0.00

5.0

3.4

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

23.4

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.91

0.00

3.1

2.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

3.9

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.98

0.00

5.0

3.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.92

0.00

1.0

1.6

pmol/l

5.6

14.1

—

(3000285) Sodium [Moles/volume] in Blood

0.92

0.00

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.89

0.00

1.0

1.3

ug/l

80.6

139.8

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

11.0

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.0

—

12.9

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.8

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(4212803)

0.92

0.00

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

600

1.00

0.00

1.4

1.3

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.99

0.00

1.4

75.2

71.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_IBD_STRICT and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_IBD_STRICT	1.085 [0.97, 1.21]	0.14
Birth year	0.998 [0.99, 1.01]	0.612

During the follow-up period (1.1.1998 — 31.12.2019), 1175 out of 19933 females with K11_IBD_STRICT died.

Males

Parameter	HR [95% CI]	p-value
K11_IBD_STRICT	1.013 [0.91, 1.13]	0.804
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1725 out of 22941 males with K11_IBD_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have K11_IBD_STRICT.

N-year risk	Females	Males
1	0.109%	0.171%
5	0.651%	0.991%
10	1.785%	2.637%
15	3.486%	5.091%
20	6.223%	8.625%

Relationships between endpoints

↥

Index endpoint: K11_IBD_STRICT – Inflammatory bowel disease, strict (require KELA)

GWS hits: 89

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Inflammatory bowel disease, strict (require KELA)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints